• 検索結果がありません。

アーティチョーク抽出物から得られたシナロピクリンのNF-κB転写活性阻害による光老化抑制効果

N/A
N/A
Protected

Academic year: 2021

シェア "アーティチョーク抽出物から得られたシナロピクリンのNF-κB転写活性阻害による光老化抑制効果"

Copied!
37
0
0

読み込み中.... (全文を見る)

全文

(1)

Title アーティチョーク抽出物から得られたシナロピクリンのNF-κB転写活性阻害による光老化抑制効果( 本文(Fulltext) ) Author(s) 田中, 友香 Report No.(Doctoral Degree) 博士(薬科学) 連創博甲第25号 Issue Date 2014-03-25 Type 博士論文 Version ETD URL http://hdl.handle.net/20.500.12099/49053 ※この資料の著作権は、各資料の著者・学協会・出版社等に帰属します。

(2)

࢔࣮ࢸ࢕ࢳ࣮ࣙࢡᢳฟ≀࠿ࡽᚓࡽࢀࡓ

ࢩࢼࣟࣆࢡࣜࣥࡢ

NF-

κB ㌿෗άᛶ㜼ᐖ࡟ࡼࡿ

ග⪁໬ᢚไຠᯝ

Cynaropicrin from Cynara scolymus L. suppresses photoaging of skin

by inhibiting the transcription activity of nuclear factor- kappa B

2014

(3)

┠ḟ ┠ḟ ┠ḟ ┠ḟ ⥴ゝ    3 ヨ㦂ᮦᩱ࡜ヨ㦂᪉ἲ 1. ᮦᩱ࡜ヨ⸆ 13 2. ⣽⬊ᇵ㣴 13 3. 㑇ఏᏊᑟධ࡜ࣝࢩࣇ࢙࣮ࣛࢮ࢔ࢵࢭ࢖ 14 4. bFGF ࡜ MMP-1 ࡢᐃ㔞 14 5. ࣓ࣛࣀࢧ࢖ࢺቑṪ ᐃ 15 6. ච␿ᰁⰍ࡟ࡼࡿ p65 ᒁᅾࡢほᐹ 15 7. UVB ↷ᑕ⓶⭵ࣔࢹ࣐ࣝ࢘ࢫ 15 8. ⤫ィゎᯒ 17 ⤖ᯝ 1. NF-κB ㌿෗άᛶ㜼ᐖస⏝ 17 2. ࢩࢼࣟࣆࢡࣜࣥ࡟ࡼࡿ NF-κB ࡬ࡢస⏝ᶵᡤ 20 3. bFGF ࠾ࡼࡧ MMP-1 ⏘⏕࡟࠾ࡅࡿ⏘⏕㜼ᐖస⏝ 21 4. ࣓ࣛࣀࢧ࢖ࢺቑṪ࡟࠾ࡅࡿ㜼ᐖຠᯝ 22 5. ࢩࢼࣟࣆࢡࣜࣥࡢ࣐࢘ࢫ⤒ཱྀᢞ୚࡟ࡼࡿ⾲⓶⫧ཌ࠾ࡼࡧ࣓ࣛࢽࣥ⏘⏕ࡢᢚไຠᯝ 23 ⪃ᐹ 27 ⤖ㄽ 28

(4)

ㅰ㎡ 28 ཧ⪃ᩥ⊩ 29 ཧ⪃㈨ᩱ࣭⥲ㄝ 35

(5)

⥴ゝ ⥴ゝ ⥴ゝ ⥴ゝ  㔝⳯ࡸᯝ≀ࡀ㇏ᐩ࡞㣗஦ࡣ೺ᗣ⥔ᣢ࡟Ḟ࠿ࡏ࡞࠸ࡇ࡜ࡣᗈࡃㄆ▱ࡉࢀ࡚࠸ࡿࠋཌ⏕ປാ ┬ࡢ㐠ႠࡍࡿWeb ࢧ࢖ࢺࠊe-࣊ࣝࢫࢿࢵࢺ࡛ࡶ㔝⳯ࡢ᭷┈ᛶ࡟ࡘ࠸࡚⤂௓ࡋࠊ⏕ά⩦័⑓ ࢆண㜵ࡋࠊ೺ᗣ⥔ᣢࡢࡓࡵ࡟㔝⳯㢮ࡢ1 ᪥ 350g ௨ୖࡢᦤྲྀࢆ᥎ዡࡋ࡚࠸ࡿࠋࡇࡢᵝ࡞㔝⳯ ࡸᯝ≀ࡢ᭷ຠᛶࡣ᳜≀ࡢ≉␗ⓗ࡞ᡂศ࡛࠶ࡿphytochemicals ࡟ࡼࡿࡶࡢ࡜ࡉࢀ࡚࠸ࡿ1ࠋ␿ Ꮫㄪᰝ࠿ࡽࡶphytochemicals ࢆྵࡴ㣗஦࡟ࡼࡾ⒴ࡸ⅖⑕ᛶ⑌ᝈࠊᚰ⾑⟶⑌ᝈ࡞࡝ࡢ៏ᛶ㞀 ᐖࢆᢚไࡋࠊ࢔ࣝࢶࣁ࢖࣐࣮ࡸࣃ࣮࢟ࣥࢯࣥ⑓ࡢࣜࢫࢡࢆῶᑡࡉࡏࡿ࡜ሗ࿌ࡉࢀ࡚࠸ࡿ1 Phytochemicals ࡣ᳜≀୰࡟Ꮡᅾࡍࡿ஧ḟ௦ㅰ⏘≀ࡢࡇ࡜ࢆ࠸࠺ࠋ᳜≀ࡀᙉ࠸⣸እ⥺ࡸẼೃࠊ ᐖ⹸ࡸື≀࡞࡝ࡢᵝࠎ࡞⎔ቃ࣭እᩛ࠿ࡽ㌟ࢆᏲࡿࡓࡵ࡟⮬ࡽసࡾฟࡋࡓᶵ⬟ᛶᡂศ࡛ࠊⰍ ࡸ㤶ࡾࠊ㎞࿡ࠊⱞ࿡࡞࡝࡟ྵࡲࢀࡿ㸦⾲㸯㸧2ࠋ୍⯡ⓗ࡟ࡣ㏻ᖖࡢ㌟య⥔ᣢ࡟ࡣᚲせ࡜ࡉࢀ ࡞࠸ࡀ೺ᗣ࡟Ⰻ࠸ᙳ㡪ࢆ୚࠼ࡿྍ⬟ᛶࡀ࠶ࡿ᳜≀⏤᮶ࡢ໬ྜ≀࡜ࡋ࡚ὀ┠ࡉࢀࠊ୍⯡㣗ရ ࡜ࡋ࡚㣗ࡉࢀࡿࡔࡅ࡛࡞ࡃࠊ໬⢝ရࡸ೺ᗣ㣗ရ࡞࡝࡟ከࡃ㓄ྜࡉࢀ࡚࠸ࡿࠋ౛࠼ࡤࠊࣈࢻ ࢘ࡢ࢔ࣥࢺࢩ࢔ࢽࣥࠊⲔࡢ࢝ࢸ࢟ࣥࠊࢽࣥࢪࣥࡸ࠿ࡰࡕࡷࡢș㸫࢝ࣟࢸࣥࠊࢺ࣐ࢺࡢࣜࢥ ࣆࣥ࡞࡝ࡀⰋࡃ▱ࡽࢀ࡚࠸ࡿࠋᮏ᮶ࠊphytochemicals ࡣࠊ᳜≀ࡀᐖ⹸࡞࡝࠿ࡽ㌟ࢆᏲࡿࡓ ࡵ࡟᳜≀ෆ࡛సࡾฟࡍࡶࡢ࡛ẅ⳦ຠᯝࡸᚷ㑊ຠᯝࢆ♧ࡍࠋࡋࡓࡀࡗ࡚㧗⏝㔞࡛ᦤྲྀࡋࡓሙ ྜࠊⓎ⒴≀㉁ࡸ⚄⤒ẘ࡜࡞ࡾ࠺ࡿࡀࠊప⏝㔞࡛ᦤྲྀࡋࡓሙྜࠊ㐺ᛂྍ⬟࡞⣽⬊ࢫࢺࣞࢫᛂ ⟅⤒㊰ࢆάᛶ໬ࡋ೺ᗣ࡟᭷┈࡞ാࡁࢆࡍࡿ1,2ࠋࡇࡢᵝ࡞⏝㔞࡟ᛂࡌ࡚㏫ࡢຠᯝࢆᘬࡁ㉳ࡇ ࡍ⌧㇟ࡣ⏕≀Ꮫࡸ⸆๣࡛ᗈࡃほᐹࡉࢀ”hormesis” ࡜ゝࢃࢀ࡚࠸ࡿ1-3ࠋ    Phytochemicals ࡢ hormesis ຠᯝ࡟ࡼࡾࠊయࢆᵓᡂࡍࡿྛ⣽⬊ࡀࢫࢺࣞࢫ࡟⪏࠼ࡿࡓࡵࡢᢠ

(6)

㓟໬㓝⣲ࠊࢱࣥࣃࢡ㉁ࢩࣕ࣌ࣟࣥࠊࣇ࢙࣮ࢬ-2 㓝⣲ࠊ⚄⤒ᰤ㣴ᅉᏊ࡞࡝ࡢ⏘⏕ࢆಁ㐍ࡉࡏࠊ ⚄⤒⣽⬊ࡢಖㆤస⏝ࡸᢠ⒴స⏝ࠊ೺ᗣಁ㐍స⏝ࢆ♧ࡍࡇ࡜ࡀሗ࿌ࡉࢀ࡚࠸ࡿ1,2 ໬⢝ရࡣ⸆஦ἲ➨2 ᮲➨ 3 㡯࡟࠾࠸࡚ࠊࡲࡓࠊᣦᐃࡉࢀࡓ⠊ᅖෆ࡛ຠ⬟࣭ຠᯝࢆ⾲♧࡛ ࡁࡿ་⸆㒊እရࡣ⸆஦ἲ➨2 ᮲➨ 2 㡯࡟࠾࠸࡚ᐃ⩏ࡉࢀ࡚࠸ࡿࠋ་⸆㒊እရࡢ୺࡞ヱᙜၟ ရࡣ⨾ⓑࡸ⑫⒔ண㜵࡟ຠᯝࡀᮇᚅ࡛ࡁࡿ⸆⏝໬⢝ရࠊ⫱ẟ๣ࠊ࣊࢔࣮࢝ࣛࠊṑ࿘⑓࣭⹸ṑ ண㜵ࡢṑࡳࡀࡁ࡞࡝ࡀ࠶ࡿࠋࡉࡽ࡟ࠊ2001 ᖺࡢ໬⢝ရࡢつไ⦆࿴࡟ࡼࡾࡑࢀࡲ࡛ཌ⏕ປാ ኱⮧࡟ㄆྍࡉࢀࡓᡂศ௨እࡣ໬⢝ရ࡟㓄ྜ࡛ࡁ࡞࠿ࡗࡓࡀࠊ඲ᡂศ⾲♧ࢆ⩏ົ௜ࡅࡽࢀࡓ ࠺࠼࡛ࠊ⸆஦ἲ໬⢝ရᇶ‽࡛⚗Ṇ࣭ไ㝈ࡀ࠶ࡿᡂศࢆ㝖ࡁࠊྛ௻ᴗࡀᏳ඲ᛶࢆ☜ㄆࡋࡓ࠺ ࠼࡛⮬⏤࡟㓄ྜࡍࡿࡇ࡜ࡀྍ⬟࡜࡞ࡗࡓࠋ୍᪉ࠊ೺ᗣ㣗ရࡣᗈࡃ೺ᗣࢆቑ㐍ࡉࡏࡿ┠ⓗ࡛ ㈍኎ࠊ฼⏝ࡉࢀࡿ㣗ရ඲⯡ࢆᣦࡋࠊἲᚊୖࠊᐃ⩏ࡣࡉࢀ࡚࠸࡞࠸ࠋࡑࡇ࡛ࠊ1991 ᖺ࡟೺ᗣ ቑ㐍ἲ࡟ࡼࡾ≉ᐃಖ೺⏝㣗ရࡀᐃ⩏ࡉࢀࠊᅜࡢᐃࡵࡓつ᱁ࡸᇶ‽ࢆ‶ࡓࡍ㣗ရ࡟ࡘ࠸࡚ࡣ ಖ೺ᶵ⬟ࡢ⾲♧ࡀྍ⬟࡟࡞ࡗࡓࠋࡇࡢᵝ࡞ὶࢀ࠿ࡽ୍⯡ᾘ㈝⪅ࡣ໬⢝ရࡸ೺ᗣ㣗ရࡢᡂศ ࡢᶵ⬟ᛶ࡟ࡘ࠸࡚┠࡟ࡍࡿᶵ఍ࡀቑ࠼ࠊPhytochemicals ࡟ࡘ࠸࡚ࡶᵝࠎ࡞࣓ࢹ࢕࢔࡛⤂௓ ࡉࢀࠊㄆ▱ࡉࢀࡿࡼ࠺࡟࡞ࡗ࡚࠸ࡿࠋ౛࠼ࡤࠊ་⸆㒊እရࡢ⨾ⓑᡂศ࡛࠶ࡿ࢔ࣝࣈࢳࣥࡣ ࢥࢣࣔࣔࡸ࢘࣡࢘ࣝࢩ⏤᮶ࡢࣇ࢙ࣀ࣮ࣝᛶ㓄⢾య࡛࣓ࣛࢽࣥࡢྜᡂ࡟㛵ࢃࡿ㓝⣲ࠊࢳࣟࢩ ࢼ࣮ࢮࡢ㜼ᐖ࡟ࡼࡾ⨾ⓑస⏝ࢆ♧ࡍࠋࡲࡓࠊすὒࣁ࣮ࣈ࡛࠶ࡿ࣑࣮࢝ࣔࣝ࠿ࡽᢳฟࡉࢀࡓ ࣑࢝ࣔࣛET ࡶ」ᩘࡢ Phytochemicals ࢆ᭷ຠᡂศ࡜ࡍࡿ⨾ⓑᡂศ࡜ࡋ࡚ᐇ⏝໬ࡉࢀ࡚࠸ࡿࠋ ࡲࡓࠊ2011 ᖺ࡟ࡣࠊ་⸆㒊እရ௨እࡢ୍⯡໬⢝ရ࡟࠾࠸࡚ࢩ࣡࡟㛵ࡍࡿຠᯝࢆㅻ࠺ࡇ࡜ࡀ ㄆྍࡉࢀࡓࠋ᪥ᮏࢆྵࡵୡ⏺࡛⮬⏕ࡍࡿࣄ࣓ࣇ࢘ࣟ࠿ࡽᢳฟࡉࢀࡿᡂศࡣࠊ⣸እ⥺࡟ࡼࡾ άᛶ໬ࡍࡿ࣐ࢫࢺࢭࣝ⏤᮶ࡢ㓝⣲ࠊࢺࣜࣉࢱ࣮ࢮࢆ㜼ᐖࡍࡿࠋࢺࣜࣉࢱ࣮ࢮࡣࠊ⣽⬊እ࣐

(7)

ࢺࣜࢵࢡࢫࡸᇶᗏ⭷ࢆศゎࡋࠊග⪁໬࡟㛵ಀࡍࡿ࡜ࡉࢀ࡚࠸ࡿ4ࠋࡋࡓࡀࡗ࡚ࠊࣄ࣓ࣇ࢘ ࣟᡂศࡣ⣸እ⥺࡟ࡼࡾᘬࡁ㉳ࡇࡉࢀࡿࢺࣜࣉࢱ࣮ࢮࢆ㜼ᐖࡋࠊࢥ࣮ࣛࢤࣥࡸᇶᗏ⭷ࡢศゎ ࡟ࡼࡿࢩ࣡ࡢᙧᡂࢆᢚไࡍࡿග⪁໬ᢚไస⏝ࢆ♧ࡍࠋ኱㇋ࡢ࢖ࢯࣇࣛ࣎ࣥࡣዪᛶ࣍ࣝࣔࣥ ࡛࠶ࡿ࢚ࢫࢺࣟࢤࣥࣞࢭࣉࢱ࣮࡟⤖ྜࡍࡿࡇ࡜ࡀሗ࿌ࡉࢀ࡚࠾ࡾࠊ࣍ࣝࣔࣥᵝάᛶࢆ᭷ࡍ ࡿࡇ࡜ࡀ▱ࡽࢀ࡚࠸ࡿ5ࠋዪᛶࡣ᭦ᖺᮇ࡟ධࡿ࡜ዪᛶ࣍ࣝࣔࣥ⏘⏕㔞ࡀపୗࡋࠊ᭦ᖺᮇ㞀 ᐖࢆᘬࡁ㉳ࡇࡍAࠋࡇࡢ㝿ࠊ⓶⭵࡟࠾࠸࡚ࡶ┿⓶ᵓᡂᡂศ࡛࠶ࡿࢥ࣮ࣛࢤࣥࡸ࢚ࣛࢫࢳࣥ ࡢ᪂⏕ࡀῶᑡࡍࡿࡇ࡜࡛ࢩ࣡ࡸࡓࡿࡳࡢཎᅉ࡜࡞ࡿࠋ኱㇋࢖ࢯࣇࣛ࣎ࣥࡣዪᛶ࣍ࣝࣔࣥᵝ άᛶࢆ♧ࡍࡇ࡜࠿ࡽࠊᨃఝⓗ࡟࣍ࣝࣔࣥࡢ୙㊊ࢆ⿵࠸⨾ᐜຠᯝࢆ♧ࡍࠋࢥ࢞ࢿࣂࢼ࡟ྵࡲ ࢀࡿࣂ࢖࢝ࣜࣥࠊࣂ࢖࢝ࣞ࢖ࣥ࡟ࡣᙉ࠸ᢠ㓟໬స⏝ࡀㄆࡵࡽࢀࠊάᛶ㓟⣲࡟ࡼࡿ⣽⬊㞀ᐖ ࢆ㍍ῶࡍࡿࡇ࡜ࡀ▱ࡽࢀ࡚࠸ࡿ6ࠋάᛶ㓟⣲ࡣ㌟యࢆㆤࡿᶵᵓࡢࡦ࡜ࡘ࡛ࡣ࠶ࡿࡀࠊ㐣๫ ࡞άᛶ㓟⣲ࡣᚲせ௨ୖ࡟㌟యࢆᵓᡂࡍࡿ⣽⬊ࡸྛ✀⺮ⓑ㉁➼ࢆ◚ቯࡍࡿࡇ࡜ࡀ▱ࡽࢀ࡚࠾ ࡾࠊࡇࢀࡀ⪁໬ࡸ⑌⑓ࡢཎᅉ࡜ၐ࠼ࡿᏛ⪅ࡶ࠸ࡿAࠋ≉࡟⣸እ⥺ࡣ⓶⭵ෆ࡛ࡢάᛶ㓟⣲ࡢ ቑຍࢆᘬࡁࡇࡍࡓࡵࠊάᛶ㓟⣲࡟ࡼࡿ㞀ᐖࢆ㏿ࡸ࠿࡟ண㜵ᨵၿࡍࡿᚲせࡀ࠶ࡿࠋࡇࡢᢠ㓟 ໬ᶵ⬟ࢆྲྀࡾධࢀࡿࡓࡵ࡟ࠊ┤᥋⫙࡟ሬᕸࡍࡿࡇ࡜ࡀྍ⬟࡞໬⢝ရࡣ᭷ຠ࡞ᡭẁࡢࡦ࡜ࡘ ࡛࠶ࡾࠊࡑࡢ㟂せࡀ㧗ࡲࡗ࡚࠸ࡿࠋࡑࢀ௨እ࡟ࡶPhytochemicals ࡟ࡼࡿ hormesis ຠᯝࢆᛂ ⏝ࡋ࡚࠸ࡿ࡜⪃࠼ࡽࢀࡿ᳜≀࢚࢟ࢫࡣᩘⓒ✀㢮࡟ࡶཬࡧࠊከࡃࡢ໬⢝ရࠊ་⸆㒊እရࠊ೺ ᗣ㣗ရ࡟ῧຍࡉࢀ࡚࠸ࡿࠋ 2012 ᖺ࡟ㄪᰝ఍♫࢖ࣥࢸ࢖࣮ࢪ࡟ࡼࡿ 10~70 ௦ࡢ⏨ዪᑐ㇟ࡢㄪᰝ࡛ࡣ೺ᗣ㣗ရ࣭ࢧࣉࣜ ࣓ࣥࢺࡢᕷሙつᶍࡣ1 ඙ 4 ༓൨෇࡟ࡶࡢࡰࡿࠋ೺ᗣ㣗ရ࡟ࡣࠊ⨾⫙࣭⫙ࢣ࢔ࠊ೺ᗣ⥔ᣢࠊ 㛵⠇ࡢ೺ᗣ⥔ᣢࠊῶ㔞࡞࡝ᵝࠎ࡞࢝ࢸࢦ࣮ࣜࡀᏑᅾࡍࡿࡀࠊ᭱ࡶ኱ࡁ࡞ᕷሙࡣ⨾⫙࣭⫙ࢣ

(8)

࢔࡛ࡑࡢつᶍࡣ1,674 ൨෇ࠊࡘ࠸࡛೺ᗣ⥔ᣢ࣭ቑ㐍ࡢ 1,450 ൨෇࡜⥆ࡃࠋࡇࢀࡣ⏨ᛶࡼࡾࡶ ዪᛶࠊ≉࡟40 ௦௨ୖࡢዪᛶࡢ฼⏝⪅ࡀከ࠸ࡇ࡜࠿ࡽ࢔ࣥࢳ࢚࢖ࢪࣥࢢ࡜࠸࠺ゝⴥ࡜࡜ࡶ࡟ ೺ᗣ㣗ရ࡛ࡶ⨾ᐜ࡟㛵ࡍࡿὀ┠ᗘࡀ㧗࠸ࡓࡵ࡜ᛮࢃࢀࡿࠋ ⣸እ⥺ࡣࠊ⓶⭵ࡢග⪁໬ࢆᘬࡁ㉳ࡇࡍ᭷ᐖ࡞⎔ቃせᅉࡢࡦ࡜ࡘ࡛࠶ࡿ7ࠋග⪁໬ࡣ៏ᛶ ⓗ࡞⣸እ⥺↷ᑕ࡟ࡼࡗ࡚⓶⭵ࡀ᪩ᮇ࡟⪁໬ࡋࡓ≧ែ࡛ࠊ⩦័ⓗ࡟ኴ㝧ගࢆᾎࡧࡓ⪁ேࡢ⓶ ⭵ࡣ⾰᭹࡛そࢃࢀࡓ㒊ศ࡜㟢ฟࡋࡓ㒊ศࢆẚ㍑ࡋࡓሙྜࠊ㟢ฟ㒊ศࡢ᪉ࡀࡼࡾ⪁໬ࡋ࡚ぢ ࠼ࡿ8ࠋ୍⯡࡟ᖺࢆ㔜ࡡࡿࡈ࡜࡟ᖺ┦ᛂࡢ㢦❧ࡕ࡟࡞ࡗ࡚ࡃࡿࡀࠊ↓ព㆑࡟ࡇࡢุ᩿ᇶ‽ ࡜࡞ࡗ࡚࠸ࡿࡢࡀࠊࢩ࣡ࠊࡓࡿࡳࠊࢩ࣑࡛࠶ࡿAࠋࡇࡢኚ໬ࡢ≉ᚩࡣࠊே✀ࡈ࡜࡟␗࡞ࡿࠋ ౛࠼ࡤࠊ࣓ࣛࢽࣥⰍ⣲ࡢከ࠸㯮ேࡣ⣸እ⥺⪏ᛶࡀ㧗ࡃࠊࢩ࣡࡞࡝ࡀᙧᡂࡉࢀ࡟ࡃ࠸ࠋ୍᪉ࠊ ࣓ࣛࢽࣥⰍ⣲ࡢᑡ࡞࠸ⓑேࡣẚ㍑ⓗ┿⓶࡬ࡢࢲ࣓࣮ࢪࡀ㧗ࡃ࡞ࡿࡇ࡜࡛ࠊࢩ࣡ࡸࡓࡿࡳࡀ ࠾ࡁࡸࡍ࠸ࠋࡑࡢ୰㛫࡛࠶ࡿ㯤Ⰽே✀ࡣࠊ㐺ᗘ࡟⣸እ⥺㜵ᚚࡍࡿࡓࡵࢩ࣡ࡸࡓࡿࡳࡣⓑே ࡟ẚ࡭࡚ᑡ࡞࠸ࡀࠊ࣓ࣛࢽࣥⰍ⣲ࡢ␗ᖖ⏘⏕࡟ࡼࡿࢩ࣑ࡀࡼࡾ┠❧ࡕࡸࡍ࠸ഴྥࡀ࠶ࡿࠋ ࡲࡓࠊ⣸እ⥺ࡢᙉ࠸࣮࢜ࢫࢺࣛࣜ࢔࡛ࡣ೺ᗣ⿕ᐖࢆண㜵ࡍࡿ┠ⓗ࡛ࠊᅜ⟇࡜ࡋ࡚  ᖺ௦ ࡟ࠕࢫࣜࢵࣉࠊࢫࣟࢵࣉࠊࢫࣛࢵࣉࠊࣛࢵࣉ㸦6OLS6ORS6ODS:UDS㸧ࠖࣉࣟࢢ࣒ࣛࡀᑟධ ࡉࢀ࡚࠸ࡿࠋࡇࢀࡣࠊ㛗ࡑ࡛ࢆ╔ࡿࠊ᪥↝ࡅṆࡵࢆሬࡿࠊᖗᏊࢆ࠿ࡪࡿࠊࢧࣥࢢࣛࢫࢆࡍ ࡿࡇ࡜ࢆ᥎ዡࡍࡿࡶࡢ࡛࠶ࡾࠊ⣸እ⥺ࡢ೺ᗣ⿕ᐖࡀ῝้࡞ၥ㢟࡛࠶ࡿࡇ࡜ࢆ≀ㄒࡗ࡚࠸ࡿࠋ ᪥ᮏ࡟࠾࠸࡚ࡶࠊ࠿ࡘ࡚ẕᏊᡭᖒ࡟ࡣ᪥ගᾎࡀ᥎ዡࡍࡿグ㏙ࡀ࠶ࡗࡓࡀࠊ ᖺࡼࡾ๐㝖 ࡉࢀ࡚࠸ࡿࠋ᪥ගᾎࡣࣅࢱ࣑ࣥ ' ࢆయෆ࡛సࡿࡓࡵ࡟ᚲせ࡜ࡉࢀ࡚࠸ࡓࡀࠊ⌧ᅾࡣ㏻ᖖࡢ 㣗஦࡛౪⤥ྍ⬟࡛࠶ࡿࡓࡵࡑࡢᜠᜨࡣᑡ࡞࠸࡜ุ᩿ࡉࢀࡓࠋ ௒ᅇࠊᡃࠎࡣ⣸እ⥺࡟ࡼࡗ࡚ࡶࡓࡽࡉࢀࡿ⓶⭵⪁໬ࠊࡍ࡞ࢃࡕ⓶⭵ග⪁໬࡟╔┠ࡋࡓࠋ

(9)

⣸እ⥺ࡣࠊ࢖ࣥࢱ࣮ࣟ࢖࢟ࣥ-1㸦IL-1㸧ࡸ⭘⒆ቯṚᅉᏊ࢔ࣝࣇ࢓㸦TNF-α㸧࡞࡝ࡢࢧ࢖ࢺ࢝ ࢖ࣥࢆศἪࡉࡏࠊ⅖⑕ࣉࣟࢭࢫࢆㄏᑟࡍࡿࠋࡑࡢ⤖ᯝࠊ⣸እ⥺ࢆ↷ᑕࡉࢀࡓ⓶⭵ࡣࠊ⓾ࡸ ࣓࢟ࡢ஘ࢀࠊ஝⇱ࠊࡓࡿࡳ࡞࡝ࡢ≉ᚩⓗእほࡀㄆࡵࡽࢀࡿ8,9ࠋ⾲2 ࡟♧ࡋࡓ࡜࠾ࡾຍ㱋࡟ ࡼࡿ⮬↛⪁໬࡜ග⪁໬࡟ࡣእほࡢ᫂ࡽ࠿࡞㐪࠸ࡔࡅ࡛࡞ࡃࢣࣛࢳࣀࢧ࢖ࢺࡸ࣓ࣛࣀࢧ࢖ࢺ ࡞࡝ࡢ⣽⬊ࡸ⏘⏕ࡉࢀࡿᡂศ࡟ࡶ㐪࠸ࡀㄆࡵࡽࢀࡿBࠋࡇࢀࡽࡢኚ໬࡟ࡣࠊࢣࣛࢳࣀࢧ࢖ ࢺࡸ࣓ࣛࣀࢧ࢖ࢺࡢ㐣ቑṪ࡜ࢥ࣮ࣛࢤࣥ⥺⥔ࡢศゎࡀ㛵୚ࡋ࡚࠸ࡿ10,11ࠋࡇࡢ⓶⭵ග⪁໬ ࡢⓎ⏕ᶵᗎ࡟ࠊ㌿෗ᅉᏊNuclear factor κB 㸦NF-κB㸧ࡀ῝ࡃ㛵୚ࡋ࡚࠸ࡿࡇ࡜ࡀ㏆ᖺሗ࿌ ࡉࢀ࡚࠸ࡿ8,9ࠋNF-κB ࡣࠊ⅖⑕࡟㛵ࢃࡿ㔜せ࡞㌿෗ᅉᏊ࡜ࡋ࡚ࠊ㛗ᖺ࡟ࢃࡓࡾ་⒪ࡢศ㔝 ࡛◊✲ࡀ㔜ࡡࡽࢀ࡚ࡁࡓࠋࡓ࡜࠼ࡤࠊNF-κB ࡣࡀࢇࡸ࣐ࣜ࢘ࢳࡢ⑓ែ㐍⾜࡟㛵୚ࡋ࡚࠾ࡾ 12,13ࠊࡑࡢ㜼ᐖ๣ࡢ㛤Ⓨࡀୡ⏺୰ࡢ◊✲ᶵ㛵࡛࡞ࡉࢀ࡚࠸ࡿࠋNF-κB ࡑࡢࡶࡢࡣࠊ⏕࿨ά ື࡟ᚲ㡲࡞㌿෗ᅉᏊ࡛ࡣ࠶ࡿࡀࠊ௚ࡢ㌿෗ᅉᏊ࡟ẚ࡭ࠊከࡃࡢ⑌⑓࡟ࡘ࡞ࡀࡿ⅖⑕཯ᛂ࡟ 㛵୚ࡍࡿ㑇ఏᏊⓎ⌧ࢆࡼࡾከࡃ㌿෗ࡍࡿࡇ࡜࠿ࡽࠊண㜵ᨵၿ⸆࡜ࡋ࡚ࡢࢱ࣮ࢤࢵࢺ࡟࡞ࡾ ࡸࡍ࠸⫼ᬒࡀ࠶ࡿ14ࠋ⓶⭵ศ㔝࡟㛵ࡋ࡚ࡶࠊ࢔ࢺࣆ࣮ᛶ⓶⭵⅖ࡸ஝Ⓞ࡟NF-κB ࡀ῝ࡃ㛵୚ ࡋ࡚࠾ࡾ12ࠊ௚ࡢ⑌⑓࡜ྠᵝ࡟◊✲ࡀ࡞ࡉࢀ࡚࠸ࡿࠋࡋ࠿ࡋ࡞ࡀࡽࠊ⑌⑓࡟⮳ࡽ࡞࠸㌟య ࡢኚ໬࡟ᑐࡍࡿNF-κB ࡢᙳ㡪࡟ࡘ࠸࡚ࡢ▱ぢࡣᑡ࡞࠸ࠋࡓ࡜࠼ࡤࠊ⪁໬࡜࠸࠺⏕⌮⌧㇟ࡣ ☜ᐇ࡟㌟యࡢ௙⤌ࡳࢆኚ໬ࡉࡏᚓࡿ⌧㇟࡛࠶ࡿࡀࠊ⑌⑓࡛ࡣ࡞࠸ࡓࡵ✚ᴟⓗ࡟◊✲ࡀ࡞ࡉ ࢀ࡚ࡇ࡞࠿ࡗࡓࠋࡑࡢࡼ࠺࡞⫼ᬒࡢ࡞࠿ࠊ⣸እ⥺࡟ࡼࡿ⓶⭵⪁໬࡜NF-κB ࡜ࡢ㛵㐃࡟ࡘ࠸ ࡚ሗ࿌ࡀ࡞ࡉࢀࠊ⣸እ⥺࡟ࡼࡗ࡚άᛶ໬ࡋࡓ㐣๫࡞NF-κB ࡀ⓶⭵⪁໬ࢆಁ㐍ࡍࡿࡇ࡜ࡀ࿘ ▱ࡉࢀࡓ8,9ࠋࡋ࠿ࡋࠊ᪤Ꮡࡢ೺ᗣ㣗ရࡸ໬⢝ရࠊ་⸆㒊እရ࡟࠾࠸࡚ࡶᢠග⪁໬ຠᯝࢆㅻ ࡗࡓࡶࡢࡣ࠶ࡿࡀNF-κB ࢆࢱ࣮ࢤࢵࢺ࡜ࡋࡓ〇ရࡣ࡞࠿ࡗࡓࠋ

(10)

⓶⭵⣽⬊ෆ࡛⣸እ⥺ࡸ⅖⑕ᛶࢧ࢖ࢺ࢝࢖ࣥ࡞࡝ࡢ่⃭࡟ࡼࡾࠊNF-κB ࡀάᛶ໬ࡋࠊ࣐ ࢺࣜࢵࢡࢫ࣭࣓ࢱࣟࣉࣟࢸ࢔࣮ࢮ-1㸦MMP-1㸧ࡀ⏘⏕ࡉࢀࠊࡑࡢ⤖ᯝࠊࢥ࣮ࣛࢤࣥ⥺⥔ࡢ ◚ቯࡀ㉳ࡁࡿ15,16ࠋࡲࡓNF-κB ࡣࠊሷᇶᛶ⥺⥔ⱆ⣽⬊ᡂ㛗ᅉᏊ㸦bFGF㸧ࡢ⏘⏕ࢆಁ㐍ࡍࡿ ࡇ࡜ࡶሗ࿌ࡉࢀࠊࢣࣛࢳࣀࢧ࢖ࢺࡸ࣓ࣛࣀࢧ࢖ࢺࡢ㐣ቑṪࡢཎᅉ࡜࡞ࡿ17,18ࠋࡉࡽ࡟ࠊ⣸ እ⥺↷ᑕ࡟ࡼࡿNF-κB άᛶ໬ࢆ㏻ࡋ࡚ bFGF ⏘⏕ࡀㄏⓎࡉࢀࡿࡇ࡜ࡶሗ࿌ࡉࢀ࡚࠸ࡿ19,20 NF-κB ࡣಶูࡢࢧࣈࣘࢽࢵࢺ࡛࠶ࡿ 5 ࡘࡢ⊂❧ࡋࡓ㑇ఏᏊ NFKB1㸦p105㸧ࠊNFKB2㸦p100㸧ࠊ RelA㸦p65㸧ࠊc-rel ཬࡧ relB ࠿ࡽᡂࡿ21ࠋ࣍ࣔཪࡣ࣊ࢸࣟࢲ࢖࣐࣮࠿ࡽ࡞ࡿNF-κB ࢱࣥࣃ ࢡ㉁ࡣᶆⓗ㑇ఏᏊࡢ⤖ྜ㒊఩࡛DNA 㓄ิ࡜⤖ྜࡍࡿࡇ࡜࡛㌿෗ࢆㄪ⠇ࡍࡿ22 NF-κB ࡣ㏻ᖖࠊᢚไศᏊ࡜ࡋ࡚▱ࡽࢀࡿ inhibitor κB 㸦IκB㸧࡜⤖ྜࡋ୙άᛶ」ྜయ࡜ࡋ ࡚⣽⬊㉁࡟␃ࡲࡿࠋࡋ࠿ࡋࠊIL-1 ࡸ TNF-αࡢࡼ࠺࡞ࢧ࢖ࢺ࢝࢖ࣥ࡟ࡼࡾࣜࣥ㓟໬ࠊࣘࣅ࢟ ࢳࣥ໬ࡉࢀࡓᚋࠊIκB ࢱࣥࣃࢡ㉁ࡀศゎࡉࢀ NF-κB ࡀ᰾࡬⛣⾜ࡍࡿ23-25ࠋࡉࡽ࡟NF-κB ࡢ άᛶ໬࡟ࡼࡾග⪁໬ࡀᘬࡁ㉳ࡇࡉࢀࡓ᫬ࠊࡑࡢ㜼ᐖ๣࡛࠶ࡿparthenolide ࢆ⭡⭍ෆᢞ୚ࡋࡓ ࡜ࡇࢁࠊ⣸እ⥺↷ᑕ࡟ࡼࡿbFGF ࡸ MMP-1 ࡢ⏘⏕ࢆ㜼ᐖࡋࠊ⾲⓶ゅ໬⣽⬊ࡸ࣓ࣛࣀࢧ࢖ࢺ ࡢ㐣ቑṪࢆᢚไࡍࡿࡇ࡜ࡀሗ࿌ࡉࢀ࡚࠸ࡿ17,18,23,26Parthenolide ࡣ࢟ࢡ⛉ࢼࢶࢩࣟࢠࢡ࡟ ྵࡲࢀࡿࢭࢫ࢟ࢸࣝ࣌ࣥࣛࢡࢺࣥࡢ1 ✀࡛࠶ࡿࠋࢭࢫ࢟ࢸࣝ࣌ࣥࣛࢡࢺࣥࡣ⅖⑕ᛶ⑌ᝈࡢ ἞⒪࡟౑⏝ࡉࢀࡿ⸆⏝᳜≀ࡢ᭷ຠᡂศ࡜ࡋ࡚▱ࡽࢀࠊα−࣓ࢳࣞࣥ−γ−ࣛࢡࢺࣥ⎔ࡀᣢࡘࢳ ࣮࢜ࣝᇶ࡬ࡢ཯ᛂᛶ࡟ࡼࡗ࡚⏕⌮άᛶࢆ♧ࡍࡇ࡜ࡀ▱ࡽࢀ࡚࠸ࡿ27Parthenolide ࡣࣜࣥ㓟 ໬ࡉࢀࡓΙκB ࡢศゎࢆ㜼ᐖࡍࡿࡇ࡜࡛ NF-κB 㜼ᐖάᛶࢆ♧ࡍࡇ࡜ࡀሗ࿌ࡉࢀ࡚࠸ࡿ27 NF-κB ࡢ㜼ᐖࡣࠊ⅖⑕཯ᛂࡢᝏᚠ⎔ࢆᢚไࡋࠊ⓶⭵ࡢග⪁໬ࡢ㜵Ṇ࡟ຠᯝⓗ࡞ാࡁࢆࡍ ࡿ㸦ᅗ1㸧ࠋParthenolide ௨እ࡟ࡶኳ↛≀ࡢ୰࡟ࡣ NF-κB 㜼ᐖάᛶࢆࡶࡘ᭷┈࡞ᡂศࡢᏑᅾ

(11)

ࡀᮇᚅࡉࢀࡓࠋ ᡃࠎࡣࠊTNF-α่⃭࡟ࡼࡿ NF-κB ࡢ㌿෗άᛶ㜼ᐖ࡬ࡢస⏝ࢆ 200 ௨ୖࡢ᳜≀࢚࢟ࢫ࡛ヨ 㦂ࡋࡓࠋࡑࡢ⤖ᯝࠊ࢔࣮ࢸ࢕ࢳ࣮ࣙࢡ㸦Cynara scolymus L.㸧࡟ᙉ࠸ NF-κB ㌿෗άᛶ㜼ᐖ స⏝ࢆ☜ㄆࡋࡓ㸦ᅗ2㸧ࠋ ࢔࣮ࢸ࢕ࢳ࣮ࣙࢡࡣᆅ୰ᾏἢᓊ࠾ࡼࡧ࢔ࣇࣜ࢝໭㒊ཎ⏘ࡢ࢟ࢡ⛉ࡢ᳜≀࡛ࠊ⣙2 ࣓࣮ࢺ ࣝࡢ㧗ࡉ࡟ᡂ㛗ࡋࠊ㟷⣸Ⰽࡢⰼᘚࢆ᭷ࡍࡿࠋࡶ࡜ࡶ࡜ࡣᆅ୰ᾏ୰す㒊࡟㔝⏕ࡋࠊⴥ᯶ࢆ㣗 ⏝࡜ࡋࡓ࢝ࣝࢻࣥCynara cardunculus ࢆရ✀ᨵⰋࡋࡓࡶࡢ࡜⪃࠼ࡽࢀ࡚࠸ࡿC,Dࠋ㛤ⰼ┤๓ ࡢⷣࡸⱝⴥࢆ㔝⳯࡜ࡋ࡚㣗࡭ࡿ௚ࠊⴥࢆࣁ࣮ࣈࢸ࢕࣮࡜ࡋ࡚㣧⏝ࠊษࡾⰼ࡜ࡋ࡚㚷㈹ࡉࢀ ࡿ࡞࡝ୡ⏺୰࡛ぶࡋࡲࢀ࡚࠸ࡿEࠋ࢔࣮ࢸ࢕ࢳ࣮ࣙࢡࡢṔྐࡣྂࡃࠊ⣖ඖ๓ࡢࢠࣜࢩ࢔࣭ ࣮࣐ࣟ᫬௦࠿ࡽ㔝⳯࡜ࡋ࡚㣗ࡉࢀࠊᆅ୰ᾏᆅ᪉ࡢẸ㛫⒪ἲ࡛ࡣ⏕ࡸⴥࡢỒࢆ࣡࢖ࣥ࡟ΰࡐ ࡚⫢⮚ࡢẸ㛫⸆࡜ࡋ࡚౑⏝ࡉࢀDࠊ࣮ࣚࣟࢵࣃ࡛ࡣ࣮ࣚࢢࣝࢺ࡟ΰࡐ࡚⨾ᐜࣃࢵࢡ࡜ࡋ࡚ ⏝࠸ࡿ࡞࡝Fᵝࠎ࡞ሙ㠃࡛㔜⏝ࡉࢀ࡚࠾ࡾࠊ⌧௦࡟࠾࠸࡚ࡶ⬡⫫ࡸ࢔ࣝࢥ࣮ࣝࡢ௦ㅰࢆຓ ࡅࡿ㣗ᮦ࡜ࡋ࡚ᩱ⌮࡟⏝࠸ࡽࢀࡿࠋ⸆⌮స⏝࡜ࡋ࡚ⴥࡸⰼᡸࠊ⥲ⱖ∦࡟฼ᒀࠊᙉኊࠊ⫹Ồ ศἪಁ㐍ࠊ⾑୰ࢥࣞࢫࢸ࣮ࣟࣝపୗࠊ⫹ಖㆤ࡞࡝ࡢస⏝ࡀ▱ࡽࢀࠊື⬦◳໬ࡸ㯤⑇ࠊᾘ໬ ୙Ⰻࠊ㣗ḧ୙᣺࡟⏝࠸ࡽࢀ࡚࠸ࡿG,Hࠋ᪥ᮏ࡟ࡣỤᡞ᫬௦࡟Ώ᮶ࡋࡓࡀᅜෆ࡛ࡣ୕ᾆ༙ᓥ࡜ ᡣ⥲༙ᓥ࡛ࢃࡎ࠿࡟᱂ᇵࡉࢀ࡚࠸ࡿࡢࡳ࡛࠶ࡿCࠋ࢔࣮ࢸ࢕ࢳ࣮ࣙࢡࡣࠊ⏕⌮άᛶᡂศ࡜ ࡋ࡚ࠊࢩࢼࣜࣥࠊࣇࣛ࣎ࣀ࢖ࢻࠊ࣏ࣜࣇ࢙ࣀ࣮ࣝࠊ࢝ࣇ࢙㓟ࠊࢡࣟࣟࢤࣥ㓟ࠊ࢝ࣟࢸࣥࠊ ࣅࢱ࣑ࣥC ࡸࢭࢫ࢟ࢸࣝ࣌ࣥࣛࢡࢺࣥࡢ㸯ࡘ࡛࠶ࡿࢩࢼࣟࣆࢡࣜࣥࢆྵࡴC,Iࠋᡃࠎࡣࢤࣝ ศ㓄࣒࢝ࣛࢡ࣐ࣟࢺࢢࣛࣇ࢕࣮࡟ࡼࡗ࡚࢔࣮ࢸ࢕ࢳ࣮ࣙࢡࡢࢩࢼࣟࣆࢡࣜࣥࢆศ㞳ࡋࠊᙉ ࠸NF-κB ㌿෗άᛶ㜼ᐖస⏝ࡀ᭷ࡿࡇ࡜ࢆぢฟࡋࡓࠋ

(12)

࢔࣮ࢸ࢕ࢳ࣮ࣙࢡ࡟ࡣ࢔ࣝࢥ࣮ࣝࡸD-࢞ࣛࢡࢺࢧ࣑ࣥ࡟ࡼࡿ⫢ᶵ⬟పୗࢆ㜼ᐖࡍࡿస ⏝ࡀᩘከࡃሗ࿌ࡉࢀ࡚࠾ࡾࠊከᩘࡢࢧࣉ࣓ࣜࣥࢺࡶ㈍኎ࡉࢀ࡚࠸ࡿ28,29ࠋᡃࠎࡀ࢔࣮ࢸ࢕ ࢳ࣮ࣙࢡᢳฟ≀ࢆ⏝࠸࡚࢞ࣛࢡࢺࢧ࣑ࣥࢆ⏝࠸ࡓ⫢ᶵ⬟ホ౯ヨ㦂ࢆᐇ᪋ࡋࡓ࡜ࡇࢁࠊሗ࿌ ࡉࢀ࡚࠸ࡿ࡜࠾ࡾࠊD-࢞ࣛࢡࢺࢧ࣑ࣥ࡟ࡼࡗ࡚ୖ᪼ࡋࡓ⾑୰ࡢ GPT ್ࡀ࢔࣮ࢸ࢕ࢳ࣮ࣙࢡ ᢳฟ≀ࡢ⤒ཱྀᢞ୚࡟ࡼࡾୖ᪼ࡀᢚไࡉࢀࡓࠋࡉࡽ࡟ࠊ࢔࣮ࢸ࢕ࢳ࣮ࣙࢡᢳฟ≀࡟ࡣ↓Ỉ࢚ ࢱࣀ࣮ࣝࡢᢞ୚ࡸỈᾐᣊ᮰ࢫࢺࣞࢫ࡟ࡼࡾㄏⓎࡉࢀࡓ⫶⢓⭷യᐖࡢᢚไࡸ⫶⢓ᾮࡢቑຍࠊ ⫶⢓ᾮྵ㔞ῶᑡࢆ㜵ࡄࡇ࡜ࡶ☜ㄆࡉࢀࡓࠋࡇࡢຠᯝࡣࠊ࢔࣮ࢸ࢕ࢳ࣮ࣙࢡࡢᡂศ࡛࠶ࡿࢩ ࢼࣟࣆࢡࣜࣥ࡟ࡼࡿࡶࡢ࡜ሗ࿌ࡉࢀ࡚࠸ࡿ30ࠋࡋ࠿ࡋࠊࡇࢀࡲ࡛࡟㈍኎ࡉࢀ࡚࠸ࡿ࢔࣮ࢸ ࢕ࢳ࣮ࣙࢡࢆ୺ཎᩱ࡜ࡍࡿࢧࣉ࣓ࣜࣥࢺ࡟ࡣࠊࢩࢼࣜࣥࠊࢡࣟࣟࢤࣥ㓟࡞࡝ࡀ୺ᡂศ࡜ࡋ ࡚ྵࡲࢀ࡚࠸ࡿࡀࢩࢼࣟࣆࢡࣜࣥࡣྵࡲࢀ࡚࠸࡞࠿ࡗࡓࠋࢩࢼࣜࣥࡸࢡࣟࣟࢤࣥ㓟࡟ࡣ NF-κB 㜼ᐖάᛶࡣㄆࡵࡽࢀ࡞࠿ࡗࡓⅭࠊ᪤Ꮡ〇ရ࡟࠾࠸࡚ྠᵝࡢຠᯝࡣᮇᚅ࡛ࡁ࡞࠸࡜ᛮ ࢃࢀࡿࠋࢩࢼࣟࣆࢡࣜࣥࡣ࢔࣮ࢸ࢕ࢳ࣮ࣙࢡ௨እ࡟ࡶ࢟ࢲࢳ࢟ࢶࢿ࢔ࢨ࣑31ࡸᮌ㤶32࡞࡝ ᵝࠎ࡞࢟ࢡ⛉ࡢ᳜≀࡟ࡶྵࡲࢀࡿ࡜ሗ࿌ࡉࢀ࡚࠸ࡿࡀࠊ᳜≀࡟࠾ࡅࡿࢩࢼࣟࣆࢡࣜࣥྵ᭷ 㔞ࢆẚ㍑ࡋࡓሗ࿌ࡣࡉࢀ࡚࠸࡞࠸ࠋ࢔࣮ࢸ࢕ࢳ࣮ࣙࢡࡣࠊୡ⏺୰࡛㣗ࡉࢀࡿ㔝⳯ࡢࡦ࡜ࡘ ࡛࠶ࡿࡀࠊ୍⯡࡟ὶ㏻ࡍࡿⷣ≧ࡢⰼᡸ㒊ศ࡟ࡣࢩࢼࣟࣆࢡࣜࣥࡣ࡯࡜ࢇ࡝ྵࡲࢀ࡚࠾ࡽࡎࠊ ࡑࡢ࡯࡜ࢇ࡝ࡣⴥࡢ୰࡟Ꮡᅾࡋ࡚࠸ࡿࠋࡍ࡞ࢃࡕࠊ௒ᅇNF-κB 㜼ᐖάᛶࢆぢฟࡋࡓࢩࢼࣟ ࣆࢡࣜࣥࡣࡇࢀࡲ࡛༑ศ࡞◊✲ࡀ࡞ࡉࢀ࡚࠸࡞࠸ࡔࡅ࡛࡞ࡃࠊࡑࡢ⸆⌮άᛶࡶ᭷ຠ࡟฼⏝ ࡛ࡁ࡚࠸࡞࠿ࡗࡓྍ⬟ᛶࡀ㧗࠸ࠋ ᮏ◊✲࡛ࡣࢩࢼࣟࣆࢡࣜࣥࡢNF-κB ㌿෗άᛶ㜼ᐖస⏝࡜ࡑࡢస⏝ᶵᗎࠊࡉࡽ࡟࣐࢘ࢫ࡟ ࠾࠸࡚ࡢ⤒ཱྀᢞ୚࡟ࡼࡿ⓶⭵ග⪁໬㜵Ṇࡢྍ⬟ᛶ࡟ࡘ࠸᳨࡚ウࡋࡓࠋ

(13)

ྡ⛠ ྵ䜎䜜䜛᳜≀ 䜰䞁䝖䝅䜰䝙䞁 䝤䝗䜴䞉㯮⡿䞉䝤䝹䞊䝧䝸䞊 䝦䝇䝨䝸䝆䞁 䜏䛛䜣䞉䛿䛳䛥䛟 䜹䝔䜻䞁 Ⲕ䞉䝽䜲䞁 䜿䝹䝉䝏䞁 ⋢䛽䛞䞉᯿ᶲ㢮䞉䝋䝞 䜲䝋䝣䝷䝪䞁 ኱㇋䛺䛹 䝸䜾䝘䞁 䝂䝬 䜽䝻䝻䝀䞁㓟 䝁䞊䝠䞊䞉䛤䜌䛖 䜽䝹䜽䝭䞁 䜴䝁䞁䛺䛹 䝃䝫䝙䞁 䝃䝫䝙䞁 ኱㇋䞉㧗㯇䝙䞁䝆䞁 䝇䝹䝣䜷䝷䝣䜯䞁 䝤䝻䝑䝁䝸䞊䞉䜻䝱䝧䝒 䜰䝸䝹䜲䝋䝏䜰䝅䝛䞊䝖 䝽䝃䝡 䝅䝇䝔䜲䞁䝇䝹䝩䜻䝅䝗 䝙䞁䝙䜽䞉⋢䛽䛞䞉䜻䝱䝧䝒 β㻙䜹䝻䝔䞁 䝙䞁䝆䞁䞉䛛䜌䛱䜓 α㻙䜹䝻䝔䞁 䝙䞁䝆䞁䞉䛛䜌䛱䜓䞉䝖䜴䝰䝻䝁䝅 䝸䝁䝢䞁 䝖䝬䝖䞉䝇䜲䜹䞉ᰠ 䝹䝔䜲䞁 䝖䜴䝰䝻䝁䝅䞉䝩䜴䝺䞁䝋䜴䞉䝤䝻䝑䝁䝸䞊 䝊䜰䜻䝃䞁䝏䞁 䝖䜴䝰䝻䝁䝅䞉䝩䜴䝺䞁䝋䜴 β㻙䜽䝸䝥䝖䜻䝃䞁䝏䞁 䜏䛛䜣䞉䜸䝺䞁䝆 䜸䜲䝀䝜䞊䝹 䜽䝻䞊䝤 䝸䝰䝛䞁 ᯿ᶲ㢮 䝯䞁䝖䞊䝹 䝝䝑䜹 䝏䝰䞊䝹 䝍䜲䝮䞉䜸䝺䜺䝜 䜲䜸䜴໬ྜ≀ 䜹䝻䝔䞁㢮 䝔䝹䝨䞁㢮 䝣䝷䝪䝜䜲䝗 䝣䜵䝜䞊䝹㢮 䝫䝸䝣䜵䝜䞊䝹 ✀㢮 ⾲ ⾲⾲ ⾲1 ௦⾲ⓗ࡞௦⾲ⓗ࡞௦⾲ⓗ࡞௦⾲ⓗ࡞Phytochemicals ⾲ ⾲⾲ ⾲2 ⮬↛⪁໬࡜ග⪁໬ࡢẚ㍑⮬↛⪁໬࡜ග⪁໬ࡢẚ㍑⮬↛⪁໬࡜ග⪁໬ࡢẚ㍑⮬↛⪁໬࡜ග⪁໬ࡢẚ㍑ ග⪁໬⓶⭵ ᮏ᮶䛾⪁໬⓶⭵ ⾲⓶඲ᒙ ཌ䛔 ⷧ䛔 䜿䝷䝏䝜䝃䜲䝖 ከᵝ䛺⣽⬊ ᆒ୍䛺⣽⬊ ᴟᛶ䛾ᾘኻ ᴟᛶ䛾ಖᏑ 䛧䜀䛧䜀⫧኱ ㏻ᖖⴎ⦰ 䝯䝷䝜䝃䜲䝖 ⣽⬊ᩘቑຍ ⣽⬊ᩘῶᑡ 䝯䝷䝜䝋䞊䝮⏘⏕ቑຍ 䝯䝷䝜䝋䞊䝮⏘⏕୙඲ ከᵝ䛺⣽⬊ ᆒ୍䛺⣽⬊ ங㢌┿⓶ ᡥᖹ໬ ᡥᖹ໬ ⥙≧┿⓶ ⫧ཌᛶᙎᛶⴎ⦰⑕ ⷧ䛟䛺䜛 ᙎᛶ⧄⥔ ᴟ䜑䛶ቑຍ 䜋䛸䜣䛹ṇᖖ ↓ᐃᙧ䛾ሢ䜢ᙧᡂ 䝁䝷䞊䝀䞁 ⥺⥔᮰ཬ䜃⥺⥔䛿ⴭྡ䛻ῶᑡ ⥺⥔᮰䛿ኴ䛟↓㉮ྥ 䜾䝸䝁䝃䝭䝜䜾䝸䜹䞁 ⴭྡ䛻ቑຍ ㍍ᚤῶᑡ ⾲ ⓶ ┿ ⓶

(14)

ᅗ ᅗ ᅗ ᅗ1 NF-κκκκB ࡢάᛶ໬࡟ࡼࡿ⓶⭵࡬ࡢᙳ㡪ࡢάᛶ໬࡟ࡼࡿ⓶⭵࡬ࡢᙳ㡪ࡢάᛶ໬࡟ࡼࡿ⓶⭵࡬ࡢᙳ㡪ࡢάᛶ໬࡟ࡼࡿ⓶⭵࡬ࡢᙳ㡪 ᅗ ᅗ ᅗ ᅗ2 ྛ✀᳜≀࢚࢟ࢫ࡟ࡼࡿྛ✀᳜≀࢚࢟ࢫ࡟ࡼࡿྛ✀᳜≀࢚࢟ࢫ࡟ࡼࡿྛ✀᳜≀࢚࢟ࢫ࡟ࡼࡿNF-κκκκB ࡟౫Ꮡࡍࡿ㌿෗άᛶ㜼ᐖస⏝࡟౫Ꮡࡍࡿ㌿෗άᛶ㜼ᐖస⏝࡟౫Ꮡࡍࡿ㌿෗άᛶ㜼ᐖస⏝࡟౫Ꮡࡍࡿ㌿෗άᛶ㜼ᐖస⏝ ྛ✀᳜≀࢚࢟ࢫࡣ10 ಸ㔞ࡢ 30㸣࢚ࢱࣀ࣮ࣝࢆຍ࠼࡚ᾐₕࡋࠊࢁ㐣ࡋࡓࠋ4κBwt-Luc ࣉࣛࢫ࣑ࢻ࡛ࢺࣛ ࣥࢫࣇ࢙ࢡࢩࣙࣥࡉࡏࡓ293 ⣽⬊ࡣࠊ⤊⃰ᗘ࡜ࡋ࡚ 1%ࡢ᳜≀࢚࢟ࢫࢆຍ࠼ࡓ 2 ᫬㛫ᚋ 1 ng/ml ࡢ TNF-α ࡛ฎ⌮ࡋࡓࠋࡇࢀࡽࡢヨ㦂ࡣᑡ࡞ࡃ࡜ࡶ3 ᅇ⧞ࡾ㏉ࡉࢀࡓࠋ

(15)

ヨ㦂ᮦ ヨ㦂ᮦ ヨ㦂ᮦ ヨ㦂ᮦᩱ࡜ヨ㦂᪉ἲᩱ࡜ヨ㦂᪉ἲᩱ࡜ヨ㦂᪉ἲᩱ࡜ヨ㦂᪉ἲ 1. ᮦᩱ࡜ヨ⸆ᮦᩱ࡜ヨ⸆ᮦᩱ࡜ヨ⸆ᮦᩱ࡜ヨ⸆    ࢔࣮ࢸ࢕ࢳ࣮ࣙࢡᢳฟ≀ࡣࠊ Cynara scolymus L.ࡢⴥ࡟ 15 ಸ㔞ࡢ 45%࢚ࢱࣀ࣮ࣝࢆຍ࠼ ࡚ᾐₕࡋࠊࢁ㐣ᚋࠊࢁᾮࢆ⃰⦰ࠊࡑࡢᚋࠊࢩࢼࣟࣆࢡࣜࣥࡀ1%࡟࡞ࡿࡼ࠺ࠊࢹ࢟ࢫࢺࣜ ࡛ࣥㄪ〇ࡋࠊ෾⤖஝⇱ࡋࡓࠋࢩࢼࣟࣆࢡࣜࣥࣃ࢘ࢲ࣮㸦CP㸧ࡣ࢔࣮ࢸ࢕ࢳ࣮ࣙࢡᢳฟ≀࠿ ࡽࢤࣝศ㞳࣒࢝ࣛࢆ⏝࠸࡚⢭〇ࡋࠊࢩࢼࣟࣆࢡࣜࣥࡀ0.65%࡟࡞ࡿࡼ࠺ࢹ࢟ࢫࢺ࡛ࣜࣥㄪ 〇ࡋࡓࠋࢩࢼࣟࣆࢡࣜࣥࡣࠊᕷ㈍ࡢᶆရࢆbionaturis㸦Sevilleࠊࢫ࣌࢖ࣥ㸧࠿ࡽ㉎ධࡋࡓࠋ TNF-αࡣ࿴ග⣧⸆㸦Osaka, Japan㸧࠿ࡽ㉎ධࡋࡓࠋNF-κB ౫Ꮡⓗ࡟࣍ࢱࣝࣝࢩࣇ࢙࣮ࣛࢮࢆ Ⓨ⌧ࡍࡿpGL3-4kBwt-luc ࣉࣛࢫ࣑ࢻࡣ pGL3-ࣉ࣮ࣟࣔࢱ࣮࣭࣋ࢡࢱ࣮㸦Promega, Madison, W㸧࡟ HIV-1 ࢚ࣥࣁࣥࢧ࣮⏤᮶ࡢ NF-κB ⤖ྜ㓄ิ㸦GGGACTTTCC㸧ࢆ 4 ࢥࣆ࣮ᤄධࡍࡿ ࡇ࡜࡟ࡼࡗ࡚స〇ࡉࢀࡓ17,33-35ࠋNF-κB ࡢࢧࣈࣘࢽࢵࢺ࡛࠶ࡿ p65 ࢆⓎ⌧ࡍࡿࣉࣛࢫ࣑ࢻ 㸦pCMV-p65㸧ࡣࠊᡭሯࡽࡢሗ࿌ࡢ㏻ࡾస〇ࡋࡓ35ࠋ࣏࣮ࣜࢱ࣮࣭ࣉࣛࢫ࣑ࢻࡣࠊྡྂᒇᕷ ❧኱Ꮫࠊᒸᮏᩍᤵࡼࡾᥦ౪㡬࠸ࡓࠋ

2. ⣽⬊ᇵ㣴⣽⬊ᇵ㣴⣽⬊ᇵ㣴⣽⬊ᇵ㣴

293 ⣽⬊㸦ࣄࢺ⭈⏤᮶ୖ⓶⣔⣽⬊㸧㸦Riken, Tsukuba, Japan㸧ࡣ 10%FBSࠊ1 mM ࡢࢢࣝࢱ ࣑ࣥ㓟ሷࠊ100 units/ml ࡢ࣌ࢽࢩࣜࣥ࡜ 100 mg/ml ࡢࢫࢺࣞࣉࢺ࣐࢖ࢩࣥῧຍࡢ DMEM ࢆ ⏝࠸ࠊ37Υ࡛ᇵ㣴ࡋࡓࠋ⣽⬊ẘᛶࡣࠊMTT ἲ࡟ࡼࡗ࡚ホ౯ࡋࡓࠋࣄࢺṇᖖ⾲⓶࣓ࣛࣀࢧ࢖ ࢺ㸦TOYOBO, Tokyo, Japan㸧ࡣࠊ37Υ࡛ 1㸣࢘ࢩ⫾ඣ⾑Ύࠊ100 units/ml ࣌ࢽࢩࣜࣥࠊ100 μg

(16)

/ ml ࡢࢫࢺࣞࣉࢺ࣐࢖ࢩࣥῧຍࡢ࣓ࣛࢽࣥ⣽⬊ᇶᮏᇵᆅ㸦TOYOBO㸧࡛ᇵ㣴ࡋࡓࠋࣄࢺṇ ᖖ⾲⓶ゅ໬⣽⬊㸦KURABO, Osaka, Japan㸧ࡣࠊࢣࣛࢳࣀࢧ࢖ࢺᇶᮏᇵᆅ㸦KURABO㸧ࢆ⏝ ࠸ࠊ37Υ࡛ᇵ㣴ࡋࡓࠋࣄࢺṇᖖ⥺⥔ⱆ⣽⬊㸦KURABO㸧ࡣ 5㸣࢘ࢩ⫾ඣ⾑Ύࠊ100 units/ml ࣌ࢽࢩࣜࣥࠊ100 μg/ml ࡢࢫࢺࣞࣉࢺ࣐࢖ࢩࣥῧຍࡢ DMEM ࢆ⏝࠸ࠊ37Υ࡛ᇵ㣴ࡋࡓࠋ

3. 㑇ఏᏊᑟධ࡜ࣝࢩࣇ࢙࣮ࣛࢮ࢔ࢵࢭ࢖㑇ఏᏊᑟධ࡜ࣝࢩࣇ࢙࣮ࣛࢮ࢔ࢵࢭ࢖㑇ఏᏊᑟධ࡜ࣝࢩࣇ࢙࣮ࣛࢮ࢔ࢵࢭ࢖㑇ఏᏊᑟධ࡜ࣝࢩࣇ࢙࣮ࣛࢮ࢔ࢵࢭ࢖

⣽⬊࡟Fugene-6 ࢺࣛࣥࢫࣇ࢙ࢡࢩࣙࣥヨ⸆㸦Roche, Basal, Switzerland㸧ࢆ⏝࠸࡚ࣉࣛࢫ ࣑ࢻࢆ㑇ఏᏊᑟධࡋࡓࠋ12well ࣉ࣮ࣞࢺ࡛ᇵ㣴ࡉࢀࡓ⣽⬊࡟ࠊ1.5 ml ࡢ Fugene-6 ࠾ࡼࡧ 0.5 μg ࡢࣉࣛࢫ࣑ࢻ DNA ࢆΰྜࡋ࡚ᑟධࡋࡓ17,34-36ࠋ㑇ఏᏊᑟධࡢ24 ᫬㛫ᚋࠊヨ㦂ヨᩱࢆῧ ຍࡋࡓࠋࡑࡢ2 ᫬㛫ᚋ࡟ TNF-αࢆῧຍࡋ࡚ NF-κB ࢆάᛶ໬ࡉࡏࠊࡉࡽ࡟ 24 ᫬㛫ᇵ㣴ࡋࡓ ࡢࡕᅇ཰ࡋࡓࠋᅇ཰ࡋࡓ⣽⬊୰ࡢࣝࢩࣇ࢙࣮ࣛࢮάᛶࡣࠊࣝࢩࣇ࢙࣮ࣛࢮ࢔ࢵࢭ࢖ࢩࢫࢸ ࣒㸦Promega㸧࡛ ᐃࡋࡓࠋ ᐃ࡟ࡣࠊ࣑ࣝࣀ࣓࣮ࢱ࣮TD-20/20㸦Promega㸧ࢆ⏝࠸ࡓࠋ㑇 ఏᏊᑟධຠ⋡ࡣࠊෆ㒊ᶆ‽࡜ࡋ࡚pRL-TK ࣉࣛࢫ࣑ࢻࢆ⏝࠸ࠊ࣍ࢱࣝࣝࢩࣇ࢙࣮ࣛࢮάᛶ ್ࢆ࣑࢘ࢩ࢖ࢱࢣࣝࢩࣇ࢙࣮ࣛࢮάᛶ್࡟ࡼࡗ࡚㝖ࡍࡿࡇ࡜࡛⿵ṇࡋࡓࠋヨ㦂ࡣࢺࣜࣉࣜ ࢣ࣮ࢺ࡛⾜ࢃࢀࠊ⊂❧ࡋࡓ⣔࡛3 ᅇ௨ୖᐇ᪋ࡋࡓࠋ 4. bFGF ࡜࡜࡜࡜MMP-1 ࡢᐃ㔞ࡢᐃ㔞ࡢᐃ㔞ࡢᐃ㔞

ᕷ㈍ࡢEIA ࢟ࢵࢺ㸦bFGF㸸Cytimmune, College Park, MD; MMP-1㸸Amersham Biosciences, Uppsala, Sweden㸧ࢆ⏝࠸࡚ࠊᣦᐃࡉࢀࡓࣉࣟࢺࢥ࣮ࣝ࡟ᚑࡗ࡚⾜ࡗࡓࠋヨ㦂ࡣࢺࣜࣉࣜࢣ ࣮ࢺ࡛⾜ࢃࢀࠊ⊂❧ࡋࡓ⣔࡛2 ᅇ௨ୖᐇ᪋ࡋࡓࠋ

(17)

5. ࣓ࣛࣀࢧ࢖ࢺቑṪ ᐃ࣓ࣛࣀࢧ࢖ࢺቑṪ ᐃ࣓ࣛࣀࢧ࢖ࢺቑṪ ᐃ࣓ࣛࣀࢧ࢖ࢺቑṪ ᐃ

ࢣࣛࢳࣀࢧ࢖ࢺࡢᇵ㣴ୖΎ࡟ࡼࡿ࣓ࣛࣀࢧ࢖ࢺ⏘⏕ಁ㐍άᛶࢆホ౯ࡍࡿࡓࡵ࡟ࢣࣛࢳࣀ ࢧ࢖ࢺ࡟pCMV-p65Vedtor ࢆᑟධࡋࠊ24 ᫬㛫ᇵ㣴ᚋᇵᆅࢆ஺᥮ࡋࡓࠋࡑࡢᚋࠊヨ㦂ヨᩱࢆ ῧຍࡋࠊ48 ᫬㛫ᇵ㣴ᚋୖΎࢆ᥇ྲྀࡋࡓࠋ࣓ࣛࣀࢧ࢖ࢺࡣ⣽⬊ಁ㐍๣ᮍῧຍࡢ Medium154S 㸦KURABO㸧࡜ࢣࣛࢳࣀࢧ࢖ࢺᇵ㣴ୖΎࢆ 1㸸4 ࡟ΰྜࡋࡓᇵᆅ࡜஺᥮ࡋࠊࡉࡽ࡟ 72 ᫬㛫 ᇵ㣴ᚋࠊ⣽⬊ࢆᅇ཰ࡋࠊ࣓ࣛࣀࢧ࢖ࢺᩘࢆ⣽⬊ᩘ ᐃヨ⸆WST-1㸦Roche, Basal, Switzerland㸧 ࢆ⏝࠸࡚ ᐃࡋࡓࠋ

6. ච␿ᰁⰍ࡟ࡼࡿච␿ᰁⰍ࡟ࡼࡿච␿ᰁⰍ࡟ࡼࡿච␿ᰁⰍ࡟ࡼࡿp65 ࡢᒁᅾࡢほᐹࡢᒁᅾࡢほᐹࡢᒁᅾࡢほᐹࡢᒁᅾࡢほᐹ

NF-κB ࡢ⣽⬊ෆᒁᅾࢆㄪ࡭ࡿࡓࡵ࡟ࠊ293 ⣽⬊࡟ヨ㦂ヨᩱࢆῧຍᚋ 3 ᫬㛫ᇵ㣴ࡋࡓࠋ TNF-α㸦1 ng/ml㸧ῧຍ࡟ࡼࡾ NF-κB ࢆάᛶ໬ࡋࠊ25 ศᚋ࡟⣽⬊ࢆᅛᐃࡋࡓࠋࡲࡓࠊࢥࣥ ࢺ࣮ࣟࣝ⩌࡜ࡋ࡚TNF-αᮍῧຍ⩌ࢆタࡅࡓࠋ

୍ḟᢠయ࡜ࡋ࡚࢘ࢧࢠ࣭࣏ࣜࢡ࣮ࣟࢼࣝp65 ᢠయ㸦Santa Cruz Biotechnology, Inc., Santa Cruz, CA㸧ࠊ஧ḟᢠయ࡜ࡋ࡚ࣇࣝ࢜ࣞࢭ࢖ࣥ࢖ࢯࢳ࢜ࢩ࢔ࢿ࣮ࢺ࡛ᶆ㆑ࡉࢀࡓࣖࢠᢠ࢘ࢧࢠ IgG㸦Cappel, Irvine, CA㸧ࢆ⏝࠸࡚ච␿ᰁⰍࡋࠊp65 ࡢᒁᅾࢆㄪ࡭ࡓ37

7. UVB ↷ᑕ⓶⭵ࣔࢹ࣐ࣝ࢘ࢫ↷ᑕ⓶⭵ࣔࢹ࣐ࣝ࢘ࢫ↷ᑕ⓶⭵ࣔࢹ࣐ࣝ࢘ࢫ↷ᑕ⓶⭵ࣔࢹ࣐ࣝ࢘ࢫ

5 㐌㱋ࡢ㞝ᛶ DBA/2 ࣐࢘ࢫ 29 ༉ࢆ౑⏝ࡋࡓࠋ࣐࢘ࢫࡣ⣸እ⥺↷ᑕ⩌ࠊ⣸እ⥺↷ᑕ + ࢩ ࢼࣟࣆࢡࣜࣥࣃ࢘ࢲ࣮㸦CP㸧462.2 mg/kg㸦3.0 mg/kg ࢩࢼࣟࣆࢡࣜࣥ࡟┦ᙜ㸧ᢞ୚⩌ࠊ⣸ እ⥺↷ᑕ + CP 92.4 mg/kg㸦0.6 mg/kg ࢩࢼࣟࣆࢡࣜࣥ࡟┦ᙜ㸧ᢞ୚⩌ࠊࢥࣥࢺ࣮ࣟࣝ⩌࡟

(18)

ศࡅࡽࢀࡓࠋ࣐࢘ࢫ࡟ࡣẖ᪥ࠊCP ࡲࡓࡣࢥࣥࢺ࣮ࣟࣝ࡜ࡋ࡚ヨ㦂ヨᩱస〇࡟౑⏝ࡋࡓࢹ࢟ ࢫࢺࣜࣥࢆࢰࣥࢹࢆ⏝࠸࡚⤒ཱྀᢞ୚ࡋࡓࠋ⣸እ⥺↷ᑕࡣࠊ12 ᪥㛫࡛ 6 ᅇࠊ280㹼320 nm Ἴ 㛗ࡢ⣸እ⥺ࢆFL20 SE ࢧࣥࣛࣥࣉ㸦TOSHIBA, Tokyo, Japan㸧ࢆ⏝࠸࡚ 180 mJ/cm2ࡢ⏝㔞࡛ ࣐࢘ࢫ࡟↷ᑕࡋࡓࠋヨ㦂ᮇ㛫୰ࡣ⤒ཱྀᢞ୚ࢆ⾜ࡗࡓᚋࠊ㐌3 ᅇࠊ⣸እ⥺↷ᑕࢆ⾜ࡗࡓࠋ12 ᪥ᚋࠊࡍ࡭࡚ࡢ࣐࢘ࢫ࠿ࡽ⪥௓ࢆ᥇ྲྀࡋ∦ഃࡣࣃࣛࣇ࢕ࣥໟᇙᶆᮏ࡟ࠊࡶ࠺୍᪉ࡣ-80Υ࡟ ಖᏑࡋࡓᚋࠊ࣓ࣛࣀࢧ࢖ࢺᩘࡢィ ࡟⏝࠸ࡓࠋࣃࣛࣇ࢕ࣥໟᇙࡋࡓ⪥௓ࢆ⏝࠸࡚⾲⓶ࡢཌ ࡉࢆ ᐃࡍࡿࡓࡵࠊ࣐࣊ࢺ࢟ࢩ̺࢚ࣜࣥ࢜ࢪࣥᰁⰍ㸦HE ᰁⰍ㸧ࢆ⾜࠸ࠊගᏛ㢧ᚤ㙾ୗ࡛ ᧜ᙳࡋࠊ⏬ീゎᯒࢯࣇࢺ㸦WINROOF㸹Mitani, Fukui, Japan㸧ࢆ౑⏝ࡋ࡚ᩘ್໬ࡋࡓࠋ

ࡲࡓࠊච␿ᰁⰍ࡟ࡼࡗ࡚ቑṪ⣽⬊᰾ᢠཎ㸦PCNA㸧ࡢⓎ⌧ࢆホ౯ࡋࡓࠋࣃࣛࣇ࢕ࣥໟᇙ ᶆᮏࢆ3 μm ࡟ษࡾศࡅࠊ⬺ࣃࣛࣇ࢕ࣥࢆ⾜ࡗࡓᚋࠊDako Target Retrieval Solution㸦pH 4.0; Dako, Glostrup, Denmark㸧࡛ 121Υࠊ5 ศ㛫཯ᛂࡋᢠཎࢆ㟢ฟࡉࡏࡓࠋࣈࣟࢵ࢟ࣥࢢ⁐ᾮ㸦㸣 ࢘ࢩ⾑Ύ࢔ࣝࣈ࣑ࣥࠊ㸣࢘ࢩ⫾ඣ⾑Ύ㸧ࡢධࡗࡓPBS ࡛཯ᛂᚋࠊᢠ PCNA ึᮇᢠయ㸦 abcam, Cambridge, U.K.㸧࡛ Υࠊ ศ㛫཯ᛂࡉࡏࡓࠋࡉࡽ࡟ࠊAlexa Fluor 594 goat anti-rabbit IgG 㸦H+L㸧㸦1:200, Molecular Probes, Eugene, OR㸧࡛ࠊᐊ ࡛  ศ㛫཯ᛂࡉࡏࡓࠋࡲࡓࠊ ᰾ࢆ࣊࢟ࢫࢺ  ⁐ᾮ㸦Dojindo Laboratories, Kumamoto, Japan㸧࡟࡚ᰁⰍࡋࡓࠋ ච␿ᰁⰍᚋࠊ⺯ග㢧ᚤ㙾㸦™㸧㸦Olympus, Tokyo, Japan㸧ࢆ౑⏝ࡋ࡚ほᐹࡋࡓࠋ

⓶⭵⤌⧊୰ࡢ࣓ࣛࣀࢧ࢖ࢺᩘࡢィ ࡣࠊHiramoto ࡽ38ࡢ᪉ἲ࡟ࡼࡗ࡚⾜ࡗࡓࠋ᥇ྲྀࡋࡓ ⪥௓࠿ࡽ㌾㦵ࢆྲྀࡾ㝖ࡁࠊ37Υ⎔ቃୗ࡛ 2N NaBr ⁐ᾮ࡟㸰᫬㛫ᾐₕࡋࡓࠋࡑࡢᚋࠊ⓶⭵⤌ ⧊࠿ࡽ⾲⓶࠾ࡼࡧᇶᗏᒙࢆ๤㞳ࡋࠊDOPA ᰁⰍࢆࡋࡓࠋ㢧ᚤ㙾ୗ࡛ 5 mm2DOPA 㝧ᛶ࣓ ࣛࣀࢧ࢖ࢺᩘࢆ࢝࢘ࣥࢺࡋࠊ1 mm2࠶ࡓࡾࡢ⣽⬊ᩘ࡛♧ࡋࡓࠋ

(19)

ࡇࢀࡽࡢື≀ᐇ㦂ࡣࠊ೔⌮ㄪᰝጤဨ఍ࡢᢎㄆࢆᚓࡓᚋࠊᐇ᪋ࡉࢀࡓࠋ 8. ⤫ィศᯒ⤫ィศᯒ⤫ィศᯒ⤫ィศᯒ ࢹ࣮ࢱࡣࠊᑡ࡞ࡃ࡜ࡶ3 ᅇࡢ⊂❧ࡋࡓᐇ㦂࠿ࡽ㞟ࡵࡽࢀࡓࠋື≀ᐇ㦂ࡣࠊྛ⩌࡟ࡘࡁᑡ ࡞ࡃ࡜ࡶ7 ༉ࡢື≀࡛ᐇ⾜ࡉࢀࡓࠋࢹ࣮ࢱࡣࠊᖹᆒ +/- S.D.࡜ࡋ࡚♧ࡋࠊ⤫ィⓗ᭷ពᛶࡣࠊ ANOVA࡟ࡼࡗ࡚ㄪ࡭ࡽࢀࡓࠋ p㸺0.05 ࡞ࡽࡤࠊ⤫ィⓗ࡟᭷ពᕪ࠶ࡾ࡜ࡋࡓࠋ ⤖ᯝ ⤖ᯝ ⤖ᯝ ⤖ᯝ 1. NF-κκκκB ㌿෗άᛶ㜼ᐖస⏝㌿෗άᛶ㜼ᐖస⏝㌿෗άᛶ㜼ᐖస⏝㌿෗άᛶ㜼ᐖస⏝ ᅗ3A ࡛♧ࡍࡼ࠺࡟ࠊࣄࢺ⭈⏤᮶ୖ⓶⣔⣽⬊ 293 ⣽⬊ࡣ TNF-α่⃭࡟ࡼࡾ NF-κB ࡢ㌿ ෗άᛶࡣቑຍࡋࡓࠋࡋ࠿ࡋTNF-αῧຍ๓࡟࢔࣮ࢸ࢕ࢳ࣮ࣙࢡᢳฟ≀ࢆῧຍࡋࡓ࡜ࡁࠊ⃰ᗘ ౫Ꮡⓗ࡟ࡑࡢάᛶࢆ㜼ᐖࡋࡓ㸦ᅗ3A㸧ࠋ ࢔࣮ࢸ࢕ࢳ࣮ࣙࢡ࡟ྵࡲࢀࡿࢭࢫ࢟ࢸࣝ࣌ࣥࣛࢡࢺࣥࡢ1 ✀࡛࠶ࡿࢩࢼࣟࣆࢡࣜࣥ 㸦ᅗ3B㸧ࡣ NF-κB ࡢ㌿෗άᛶ㜼ᐖస⏝ࢆ♧ࡋࡓ㸦ᅗ 3C㸧ࠋࡲࡓࠊ⏝࠸ࡓ⃰ᗘ࡟࠾࠸࡚᭷ ព࡞⣽⬊ẘᛶࡣㄆࡵࡽࢀ࡞࠿ࡗࡓࠋ࢔࣮ࢸ࢕ࢳ࣮ࣙࢡᢳฟ≀࡜ࢩࢼࣟࣆࢡࣜࣥࡢNF-κB ㌿ ෗άᛶࢆྠ୍ࢢࣛࣇୖ࡟♧ࡋࡓ㸦ᅗ3D㸧ࠋ࢔࣮ࢸ࢕ࢳ࣮ࣙࢡᢳฟ≀࡟ྵࡲࢀࡿࢩࢼࣟࣆࢡ ࣜࣥ⃰ᗘࢆX ㍈ୖ࡛ᥞ࠼ࡓ࡜ࡁࠊ࢔࣮ࢸ࢕ࢳ࣮ࣙࢡᢳฟ≀࡜ࢩࢼࣟࣆࢡࣜࣥࡢ NF-κB ά ᛶ㜼ᐖࡣྠ⛬ᗘ࡛࠶ࡗࡓࠋࡇࡢ⤖ᯝࡣࠊNF-κB ࡢ㌿෗άᛶࢆ㜼ᐖࡍࡿ࢔࣮ࢸ࢕ࢳ࣮ࣙࢡᢳ

(20)

ฟ≀ࡢάᛶᡂศࡀࢩࢼࣟࣆࢡ࡛ࣜࣥ࠶ࡿྍ⬟ᛶࡀᴟࡵ࡚㧗ࡃࠊ┦஌ⓗࡶࡋࡃࡣ┦ຍⓗ࡟స ⏝ࡍࡿ௚ࡢ≀㉁ࡀ࢔࣮ࢸ࢕ࢳ࣮ࣙࢡᢳฟ≀࡟ࡣྵࡲࢀ࡞࠸ࡇ࡜ࢆ♧ࡋ࡚࠸ࡿࠋ

B A

(21)

ᅗ ᅗ ᅗ ᅗ3 ࢔࣮ࢸ࢕ࢳ࣮ࣙࢡᢳฟ≀࡜ࢩࢼࣟࣆࢡࣜࣥ࡟ࡼࡿ࢔࣮ࢸ࢕ࢳ࣮ࣙࢡᢳฟ≀࡜ࢩࢼࣟࣆࢡࣜࣥ࡟ࡼࡿ࢔࣮ࢸ࢕ࢳ࣮ࣙࢡᢳฟ≀࡜ࢩࢼࣟࣆࢡࣜࣥ࡟ࡼࡿ࢔࣮ࢸ࢕ࢳ࣮ࣙࢡᢳฟ≀࡜ࢩࢼࣟࣆࢡࣜࣥ࡟ࡼࡿNF-κκκκB ㌿෗άᛶ㜼ᐖస⏝㌿෗άᛶ㜼ᐖస⏝㌿෗άᛶ㜼ᐖస⏝㌿෗άᛶ㜼ᐖస⏝ 㸦A㸧ᕥᅗ㸸࢔࣮ࢸ࢕ࢳ࣮ࣙࢡᢳฟ≀ࡢ NF-κB ㌿෗άᛶ࡬ࡢຠᯝࠋ4κBwt-Luc ࣉࣛࢫ࣑ࢻ࡛ࢺࣛࣥࢫࣇ ࢙ࢡࢩࣙࣥࡉࡏࡓ293 ⣽⬊ࡣࠊ⤊⃰ᗘ࡜ࡋ࡚ 140ࠊ280 ࡲࡓࡣ 560 μg/mL ࡢ࢔࣮ࢸ࢕ࢳ࣮ࣙࢡᢳฟ≀ࢆ ຍ࠼ࡓ2 ᫬㛫ᚋ 1 ng/ml ࡢ TNF-α࡛ฎ⌮ࡋࡓࠋࡇࢀࡽࡢヨ㦂ࡣᑡ࡞ࡃ࡜ࡶ 3 ᅇ⧞ࡾ㏉ࡉࢀࡓࠋྑᅗ㸸࢔ ࣮ࢸ࢕ࢳ࣮ࣙࢡᢳฟ≀ࡢ⣽⬊ẘᛶ ࢔࣮ࢸ࢕ࢳ࣮ࣙࢡᢳฟ≀࡟ࡼࡿ⣽⬊ẘᛶࡣほᐹࡉࢀ࡞࠿ࡗࡓࠋࢹ࣮ ࢱࡣᖹᆒsS.D.ࠊ᭷ពᕪࡣ ANOVA ࡟ࡼࡾ ** p <0.01ࠊn.s. ᭷ពᕪ࡞ࡋ࡜♧ࡋࡓࠋ 㸦B㸧ࢩࢼࣟࣆࢡࣜࣥࡢ໬Ꮫᵓ㐀 㸦C㸧ᕥᅗ㸸ࢩࢼࣟࣆࢡࣜࣥࡢ NF-κB ㌿෗άᛶ࡬ࡢຠᯝࠋ293 ⣽⬊ࡣࢩࢼࣟࣆࢡࣜࣥ㸦2ࠊ4 ࡲࡓࡣ 8 μM㸧 ࡛๓ฎ⌮ࡉࢀࠊ࢔࣮ࢸ࢕ࢳ࣮ࣙࢡᢳฟ≀࡜ྠᵝࡢ᪉ἲ࡛ࣝࢩࣇ࢙࣮ࣛࢮάᛶࢆ ᐃࡋࡓࠋྑᅗ㸸ࢩࢼࣟ ࣆࢡࣜࣥࡢ⣽⬊ẘᛶ ࢩࢼࣟࣆࢡࣜࣥ࡟ࡼࡿ⣽⬊ẘᛶࡣほᐹࡉࢀ࡞࠿ࡗࡓࠋࢹ࣮ࢱࡣᖹᆒsS.D.ࠊ᭷ព ᕪࡣANOVA ࡟ࡼࡾ ** p <0.01ࠊn.s. ᭷ពᕪ࡞ࡋ࡜♧ࡋࡓࠋ 㸦D㸧࢔࣮ࢸ࢕ࢳ࣮ࣙࢡᢳฟ≀࡜ࢩࢼࣟࣆࢡࣜࣥࡢ NF-κB ㌿෗άᛶ㜼ᐖࡢẚ㍑ C D

(22)

2. ࢩࢼࣟࣆࢡࣜࣥ࡟ࡼࡿࢩࢼࣟࣆࢡࣜࣥ࡟ࡼࡿࢩࢼࣟࣆࢡࣜࣥ࡟ࡼࡿࢩࢼࣟࣆࢡࣜࣥ࡟ࡼࡿNF-κκκκB ࡬ࡢస⏝ᶵᗎ࡬ࡢస⏝ᶵᗎ࡬ࡢస⏝ᶵᗎ࡬ࡢస⏝ᶵᗎ  ࢩࢼࣟࣆࢡࣜࣥ࡟ࡼࡿNF-κB ࡢ㌿෗㜼ᐖ࣓࢝ࢽࢬ࣒ࢆ᫂ࡽ࠿࡟ࡍࡿࡓࡵࠊᡃࠎࡣࠊ293 ⣽⬊࡬pCMV -p65 ࢆࢺࣛࣥࢫࣇ࢙ࢡࢩࣙࣥࡋࠊp65 㑇ఏᏊࢆ㐣๫Ⓨ⌧ࡉࡏࡓࠋp65 㑇ఏᏊ ࡢ㐣๫Ⓨ⌧ࡣࠊI-κB ࡢࣜࣥ㓟໬ࡸศゎ࡞࡝ࡢ NF-κB ࡢ᰾⛣⾜࡟ࡘ࡞ࡀࡿṇᖖ࡞ࢩࢢࢼࣝఏ 㐩⤒㊰ࢆࣂ࢖ࣃࢫࡋ࡚ࠊ௵ពࡢ่⃭࡞ࡋ࡟NF-κB ᶆⓗ㑇ఏᏊࡢ㌿෗࡟ᑐࡍࡿᙳ㡪ࢆࡳࡿࡇ ࡜ࡀ࡛ࡁࡿࠋᅗ4A ࡟♧ࡍࡼ࠺࡟ࠊࢩࢼࣟࣆࢡࣜࣥࡣ p65 ࡟ࡼࡿ㌿෗άᛶࢆ TNF-α่⃭࡟ ࡼࡿ㌿෗άᛶ࡜ྠᵝ࡟⃰ᗘ౫Ꮡⓗ࡟㜼ᐖࡋࡓࠋࡇࢀࡽࡢ▱ぢࡣࠊࢩࢼࣟࣆࢡࣜࣥࡢ୺せ࡞ ࢱ࣮ࢤࢵࢺࡣI-κB ࡢࣜࣥ㓟໬࡜ศゎࡢୗὶ࡛࠶ࡿࡇ࡜ࢆ♧ࡋ࡚࠸ࡿࠋࡲࡓࠊ᰾⛣⾜࡟࠾ࡅ ࡿࢩࢼࣟࣆࢡࣜࣥࡢຠᯝࢆNF-κB㸦p65㸧ࡢච␿⺯ගἲ࡟ࡼࡾㄪ࡭ࡓࠋTNF-α่⃭࡟ࡼࡾㄏ ⓎࡉࢀࡓNF-κB ࡢ᰾⛣⾜ࡣࢩࢼࣟࣆࢡࣜࣥ࡟ࡼࡾ㜼ᐖࡉࢀࡓ㸦ᅗ 4B㸧ࠋ ᅗ ᅗ ᅗ ᅗ4 p65 ࡢ㌿෗άᛶࡢ㌿෗άᛶࡢ㌿෗άᛶ࡬ࡢࢩࢼࣟࣆࢡࣜࣥࡢ㜼ᐖస⏝㸦ࡢ㌿෗άᛶ࡬ࡢࢩࢼࣟࣆࢡࣜࣥࡢ㜼ᐖస⏝㸦࡬ࡢࢩࢼࣟࣆࢡࣜࣥࡢ㜼ᐖస⏝㸦࡬ࡢࢩࢼࣟࣆࢡࣜࣥࡢ㜼ᐖస⏝㸦A㸧࡜㸧࡜㸧࡜㸧࡜NF-κκκκB ࡢ᰾⛣⾜ᢚไ㸦ࡢ᰾⛣⾜ᢚไ㸦ࡢ᰾⛣⾜ᢚไ㸦ࡢ᰾⛣⾜ᢚไ㸦B㸧㸧㸧㸧 㸦A㸧p65 ࢆ㐣๫Ⓨ⌧ࡉࡏࡓ 293 ⣽⬊࡟ࢩࢼࣟࣆࢡࣜࣥࢆ 2ࠊ4 ࡲࡓࡣ 8 μM ຍ࠼ࡓࠋࢹ࣮ࢱࡣᖹᆒsS.D.ࠊ ᭷ពᕪࡣANOVA ࡟ࡼࡾ ** p <0.01 ࡜♧ࡋࡓࠋ 㸦B㸧ࢩࢼࣟࣆࢡࣜࣥ(8 μM)ࡣ TNF-αῧຍ๓࡟ຍ࠼ࡽࢀࡓࠋ A B

(23)

3. bFGF ࠾ࡼࡧ࠾ࡼࡧ࠾ࡼࡧ࠾ࡼࡧMMP-1 ⏘⏕࡟࠾ࡅࡿ⏘⏕㜼ᐖస⏝⏘⏕࡟࠾ࡅࡿ⏘⏕㜼ᐖస⏝⏘⏕࡟࠾ࡅࡿ⏘⏕㜼ᐖస⏝⏘⏕࡟࠾ࡅࡿ⏘⏕㜼ᐖస⏝  ⣸እ⥺࡟ㄏⓎࡉࢀࡿ⓶⭵ࡢኚ໬ࡣࠊbFGF ࡜ MMP-1 ࡟ࡼࡗ࡚፹௓ࡉࢀࡿࡇ࡜ࡀ▱ࡽࢀ ࡚࠸ࡿ8,39NF-κB ࡢࢧࣈࣘࢽࢵࢺ࡛࠶ࡿ p65 ࢆᑟධࡋࡓࢣࣛࢳࣀࢧ࢖ࢺ࡛ࡣࠊᖖ࡟ NF-κB ࡀάᛶ໬ࡋࡓ≧ែ࡜࡞ࡾࠊbFGF ࡜ MMP-1 ࡢ⏘⏕ࢆㄏᑟࡉࢀࡿࡇ࡜ࡀሗ࿌ࡉࢀࡓ18,34ࠋᅗ 5A ࡟♧ࡍ࡜࠾ࡾࠊࢩࢼࣟࣆࢡࣜࣥࡣ NF-κB 㸦p65㸧ࡀ㐣๫Ⓨ⌧ࡋࡓࢣࣛࢳࣀࢧ࢖ࢺࡢ bFGF ⏘⏕ࢆ᭷ព࡟㜼ᐖࡋࡓࠋྠᵝ࡟ࠊᅗ5B ࡣࢩࢼࣟࣆࢡࣜࣥࡀ⓶⭵⥺⥔ⱆ⣽⬊࠿ࡽࡢ MMP-1 ⏘⏕ࡶ᭷ព࡟㜼ᐖࡍࡿࡇ࡜ࢆ♧ࡋ࡚࠸ࡿࠋ ᅗ ᅗ ᅗ ᅗ5 p65 ࢆ㐣๫Ⓨ⌧ࡉࡏࡓࢣࣛࢳࣀࢧ࢖ࢺ࡟࠾ࡅࡿࢆ㐣๫Ⓨ⌧ࡉࡏࡓࢣࣛࢳࣀࢧ࢖ࢺ࡟࠾ࡅࡿࢆ㐣๫Ⓨ⌧ࡉࡏࡓࢣࣛࢳࣀࢧ࢖ࢺ࡟࠾ࡅࡿࢆ㐣๫Ⓨ⌧ࡉࡏࡓࢣࣛࢳࣀࢧ࢖ࢺ࡟࠾ࡅࡿbFGF ⏘⏕㸦⏘⏕㸦⏘⏕㸦⏘⏕㸦A㸧࡜㸧࡜㸧࡜㸧࡜p65 ࢆ㐣๫Ⓨ⌧ࡉࡏࢆ㐣๫Ⓨ⌧ࡉࡏࢆ㐣๫Ⓨ⌧ࡉࡏࢆ㐣๫Ⓨ⌧ࡉࡏ ࡓ⥺⥔ⱆ⣽⬊࡟࠾ࡅࡿ ࡓ⥺⥔ⱆ⣽⬊࡟࠾ࡅࡿ ࡓ⥺⥔ⱆ⣽⬊࡟࠾ࡅࡿ ࡓ⥺⥔ⱆ⣽⬊࡟࠾ࡅࡿMMP-1 ⏘⏕㸦⏘⏕㸦⏘⏕㸦⏘⏕㸦B㸧㸧㸧࡬ࡢࢩࢼࣟࣆࢡࣜࣥࡢຠᯝ㸧࡬ࡢࢩࢼࣟࣆࢡࣜࣥࡢຠᯝ࡬ࡢࢩࢼࣟࣆࢡࣜࣥࡢຠᯝ࡬ࡢࢩࢼࣟࣆࢡࣜࣥࡢຠᯝ ⾲⓶ゅ໬⣽⬊࡜⥺⥔ⱆ⣽⬊ࡣࢩࢼࣟࣆࢡࣜࣥ4 μM ࢆຍ࠼࡚ヨ㦂ࡋࡓࠋࢹ࣮ࢱࡣᖹᆒsS.D.ࠊ᭷ពᕪࡣ ANOVA ࡟ࡼࡾ ** p <0.01ࠊ * p <0.05 ࡜♧ࡋࡓࠋ A B

(24)

4. ࣓ࣛࣀࢧ࢖ࢺቑṪ࡟࠾ࡅࡿ㜼ᐖຠᯝ࣓ࣛࣀࢧ࢖ࢺቑṪ࡟࠾ࡅࡿ㜼ᐖຠᯝ࣓ࣛࣀࢧ࢖ࢺቑṪ࡟࠾ࡅࡿ㜼ᐖຠᯝ࣓ࣛࣀࢧ࢖ࢺቑṪ࡟࠾ࡅࡿ㜼ᐖຠᯝ ⓶⭵࡟࠾࠸࡚࣓ࣛࢽࣥⰍ⣲ࢆసࡿ⾲⓶࣓ࣛࣀࢧ࢖ࢺࡣࠊ⣸እ⥺ࡸ៏ᛶⓗ࡞⅖⑕➼࡛ቑ ຍࡋࠊࡑࢀࡀ⓶⭵࡟࠾ࡅࡿ࣓ࣛࢽࣥ⏘⏕㔞ࡢቑ኱࡟ࡘ࡞ࡀࡿ࡜࠸ࢃࢀ࡚࠸ࡿ8ࠋ࣓ࣛࢽࣥ ⏘⏕㔞ࡢቑຍࡋࡓ⓶⭵࡛ࡣࠊ࣓ࣛࣀࢧ࢖ࢺᩘࡀቑ࠼࡚࠾ࡾࠊࡑࡢ㐣⛬࡟ࢣࣛࢳࣀࢧ࢖ࢺෆ ࡛సࡽࢀࡿNF-κB ౫Ꮡᛶ bFGF ࡀ㛵୚ࡋ࡚࠸ࡿࡇ࡜ࡀሗ࿌ࡉࢀ࡚࠸ࡿ17ࠋNF-κB 㸦p65㸧 ࢆ㐣๫Ⓨ⌧ࡉࡏࡓࢣࣛࢳࣀࢧ࢖ࢺࡢᇵ㣴ୖΎࢆຍ࠼࡚ࠊ࣓ࣛࣀࢧ࢖ࢺࢆᇵ㣴ࡋࡓ࡜ࡇࢁࠊ ࣓ࣛࣀࢧ࢖ࢺࡢ᭷ព࡞ቑຍࡀほᐹࡉࢀࡓࠋࡋ࠿ࡋࠊ࠶ࡽ࠿ࡌࡵࢣࣛࢳࣀࢧ࢖ࢺ࡟ࢩࢼࣟࣆ ࢡࣜࣥࢆῧຍࡋ࡚ᇵ㣴ࡍࡿ࡜࣓ࣛࣀࢧ࢖ࢺࡢቑṪࡣ㜼ᐖࡉࢀࡓ㸦ᅗ6AࠊB㸧ࠋ ᅗ ᅗ ᅗ ᅗ  p65 ࢆ㐣๫Ⓨ⌧ࡉࡏࡓࢣࣛࢳࣀࢧ࢖ࢺᇵ㣴ୖΎࡢ࣓ࣛࣀࢧ࢖ࢺቑຍ࡟ᑐࡍࡿࢩࢼࣟࣆࢡࢆ㐣๫Ⓨ⌧ࡉࡏࡓࢣࣛࢳࣀࢧ࢖ࢺᇵ㣴ୖΎࡢ࣓ࣛࣀࢧ࢖ࢺቑຍ࡟ᑐࡍࡿࢩࢼࣟࣆࢡࢆ㐣๫Ⓨ⌧ࡉࡏࡓࢣࣛࢳࣀࢧ࢖ࢺᇵ㣴ୖΎࡢ࣓ࣛࣀࢧ࢖ࢺቑຍ࡟ᑐࡍࡿࢩࢼࣟࣆࢡࢆ㐣๫Ⓨ⌧ࡉࡏࡓࢣࣛࢳࣀࢧ࢖ࢺᇵ㣴ୖΎࡢ࣓ࣛࣀࢧ࢖ࢺቑຍ࡟ᑐࡍࡿࢩࢼࣟࣆࢡ ࣜࣥࡢຠᯝ ࣜࣥࡢຠᯝ ࣜࣥࡢຠᯝ ࣜࣥࡢຠᯝ 㸦A㸧p65 ࢆ㐣๫Ⓨ⌧ࡉࡏࡓࢣࣛࢳࣀࢧ࢖ࢺ࡟ࢩࢼࣟࣆࢡࣜࣥ 4 μM ࢆຍ࠼࡚ヨ㦂ࡋࡓࠋࢹ࣮ࢱࡣᖹᆒ sS.D.ࠊ᭷ពᕪࡣ ANOVA ࡟ࡼࡾ* p <0.05 ࡜♧ࡋࡓࠋ 㸦B㸧ࢣࣛࢳࣀࢧ࢖ࢺᇵ㣴ୖΎࡢ࣓ࣛࣀࢧ࢖ࢺ࡬ࡢస⏝ࠋ B A

(25)

5. ࢩࢼࣟࣆࢡࣜࣥࡢ࣐࢘ࢫ⤒ཱྀᢞ୚࡟ࡼࡿ⾲⓶⫧ཌ࠾ࡼࡧ࣓ࣛࢽࣥ⏘⏕ࡢᢚไຠᯝࢩࢼࣟࣆࢡࣜࣥࡢ࣐࢘ࢫ⤒ཱྀᢞ୚࡟ࡼࡿ⾲⓶⫧ཌ࠾ࡼࡧ࣓ࣛࢽࣥ⏘⏕ࡢᢚไຠᯝࢩࢼࣟࣆࢡࣜࣥࡢ࣐࢘ࢫ⤒ཱྀᢞ୚࡟ࡼࡿ⾲⓶⫧ཌ࠾ࡼࡧ࣓ࣛࢽࣥ⏘⏕ࡢᢚไຠᯝࢩࢼࣟࣆࢡࣜࣥࡢ࣐࢘ࢫ⤒ཱྀᢞ୚࡟ࡼࡿ⾲⓶⫧ཌ࠾ࡼࡧ࣓ࣛࢽࣥ⏘⏕ࡢᢚไຠᯝ  ⣸እ⥺࡟ࡼࡿ⾲⓶ࡢ⫧ཌࡸⰍ⣲ỿ╔ࡀࠊ㐣๫࡞bFGF ࡟ࡼࡿࢣࣛࢳࣀࢧ࢖ࢺ8,10,11࡜࣓ ࣛࣀࢧ࢖ࢺࡢ㐣ቑṪ࠿ࡽ⏕ࡌࡿࡇ࡜ࡣࡼࡃ▱ࡽࢀ࡚࠸ࡿ39,40ࠋࡲࡓࠊNF-κB ᢚไ๣ࡢ౑⏝ ࡀUVB ↷ᑕ࡟ࡼࡿ⾲⓶ࡢ⫧ཌࢆᢚไࡍࡿࡇ࡜ࡀሗ࿌ࡉࢀ࡚࠸ࡿ17,18,34ࠋᮏヨ㦂࡛ࡣUVB ↷ᑕ࡟ࡼࡾㄏⓎࡉࢀࡿ⓶⭵㞀ᐖ࡬ࡢࢩࢼࣟࣆࢡࣜࣥࣃ࢘ࢲ࣮㸦CP㸧ࡢ⤒ཱྀᢞ୚࡟ࡼࡿᙳ㡪 ࢆㄪ࡭ࡓࠋᅗ7AࠊB ࡟♧ࡍ࡜࠾ࡾࠊࢥࣥࢺ࣮ࣟࣝ⩌࡟ẚ࡭ UV ↷ᑕ⩌ࡀ 1.7 ಸࡢ⾲⓶ࡢ⫧ ཌࢆㄏⓎࡋࡓࡢ࡟ᑐࡋ࡚ࠊ462.2 mg/kg CP㸦3.0 mg/kg ࡢࢩࢼࣟࣆࢡࣜࣥ࡟➼ࡋ࠸㸧ᢞ୚⩌ ࡛ࡣࠊࢥࣥࢺ࣮ࣟࣝ⩌࡜ྠ⛬ᗘࡲ࡛ᢚไࡋࡓࠋ ྠᵝ࡟ࠊ92.4 mg/kg CP㸦0.6 mg/kg ࡢࢩࢼ ࣟࣆࢡࣜࣥ࡟➼ࡋ࠸㸧ᢞ୚⩌࡛ࡣࠊ⾲⓶ࡢ⫧ཌࢆ᭷ព࡟ῶᑡࡉࡏࡓࠋࡇࢀࡽࡢ⤖ᯝࡣࠊࢩ ࢼࣟࣆࢡࣜࣥࡀ⃰ᗘ౫Ꮡⓗ࡟ࢣࣛࢳࣀࢧ࢖ࢺࡢ㐣ቑṪࢆᢚไࡋࡓࡇ࡜ࢆ♧ࡋ࡚࠸ࡿࠋᅗ7C ࡟♧ࡋࡓච␿ᰁⰍ࡟ࡼࡾ᳨ドࡋࡓPCNA 㝧ᛶ⣽⬊ᩘࡣࡍ࡭࡚ࡢ⩌࡛㐪࠸ࢆㄆࡵ࡞࠿ࡗࡓࠋ ࡋ࠿ࡋࠊUV ↷ᑕ⩌࡛ࡣ᭷᰾⣽⬊ᩘࡀ㢧ⴭ࡟ቑຍࡋ࡚࠸ࡓࡢ࡟ᑐࡋࠊCP ᢞ୚⩌࡛ࡣ᭷᰾⣽ ⬊ࡢቑຍࡣㄆࡵࡽࢀ࡞࠿ࡗࡓࠋ ࡲࡓࠊDOPA 㝧ᛶ࣓ࣛࣀࢧ࢖ࢺᩘࢆẚ㍑ࡋࡓ࡜ࡇࢁࠊࢥࣥࢺ࣮ࣟࣝ⩌࡟ẚ࡭ UV ↷ᑕ⩌ ࡛ࡣ4.3 ಸࡢ࣓ࣛࣀࢧ࢖ࢺቑຍࢆㄆࡵࡓࡀࠊ92.4 mg/kg ࡲࡓࡣ 462.2 mg/kg ࡢ CP ᢞ୚⩌࡛ ࡣ࣓ࣛࣀࢧ࢖ࢺࡢቑຍࡀ᭷ព࡟ᢚไࡉࢀࡓ㸦ᅗ8AࠊB㸧ࠋ

(26)

A

(27)

ᅗ ᅗ ᅗ ᅗ7 UVB↷ᑕ࡛ㄏⓎࡉࢀࡿ⾲⓶ࡢ⫧ཌ࡟ᑐࡍࡿࢩࢼࣟࣆࢡࣜࣥࡢᢚไ↷ᑕ࡛ㄏⓎࡉࢀࡿ⾲⓶ࡢ⫧ཌ࡟ᑐࡍࡿࢩࢼࣟࣆࢡࣜࣥࡢᢚไ↷ᑕ࡛ㄏⓎࡉࢀࡿ⾲⓶ࡢ⫧ཌ࡟ᑐࡍࡿࢩࢼࣟࣆࢡࣜࣥࡢᢚไ↷ᑕ࡛ㄏⓎࡉࢀࡿ⾲⓶ࡢ⫧ཌ࡟ᑐࡍࡿࢩࢼࣟࣆࢡࣜࣥࡢᢚไຠᯝຠᯝຠᯝຠᯝ 㸦A㸧 UV ↷ᑕࡋࡓ࣐࢘ࢫ⓶⭵ࡢ HE ᰁⰍ 㸦A,B㸧UV ↷ᑕ࡟ࡼࡿ⾲⓶㐣ቑṪ࡬ࡢ CP ࡢຠᯝࠋDBA/2 ࣐࢘ࢫࡣ↓సⅭ࡟ 4 ⩌࡟ศࡅࠊྛ⩌ᙜࡓࡾ ᑡ࡞ࡃ࡜ࡶ7 ༉⏝࠸ࡓࠋCP ᢞ୚⩌ࡣࠊ462.2 mg/kg㸦ࢩࢼࣟࣆࢡࣜࣥ 3 mg/kg ࡟┦ᙜ㸧ࡲࡓࡣ 92.4 mg/kg 㸦ࢩࢼࣟࣆࢡࣜࣥ0.6 mg/kg ࡟┦ᙜ㸧ࢆ㐃᪥⤒ཱྀᢞ୚ࡋࡓࠋUV ↷ᑕ⩌࡜ࢥࣥࢺ࣮ࣟࣝ⩌࡟ࡣࠊ462.2 mg/kg ࡢࢹ࢟ࢫࢺࣜࣥࢆྠᵝ࡟ᢞ୚ࡋࡓࠋࢹ࣮ࢱࡣᖹᆒsS.D.ࠊ᭷ពᕪࡣ ANOVA ࡟ࡼࡾ ** p <0.01ࠊ * p <0.05 ࡜♧ࡋࡓࠋscale bar = 20μm.

C㸧࣐࢘ࢫ⓶⭵ࡢ PCNA Ⓨ⌧ࡢච␿ᰁⰍࠋscale bar = 20μm.

(28)

ᅗ ᅗ ᅗ ᅗ  UVB↷ᑕ↷ᑕ↷ᑕ↷ᑕ࡟ࡼࡿ࣓ࣛࣀࢧ࢖ࢺቑṪ࡟ᑐࡍࡿࢩࢼࣟࣆࢡࣜࣥ࡟ࡼࡿᢚไຠᯝ࡟ࡼࡿ࣓ࣛࣀࢧ࢖ࢺቑṪ࡟ᑐࡍࡿࢩࢼࣟࣆࢡࣜࣥ࡟ࡼࡿᢚไຠᯝ࡟ࡼࡿ࣓ࣛࣀࢧ࢖ࢺቑṪ࡟ᑐࡍࡿࢩࢼࣟࣆࢡࣜࣥ࡟ࡼࡿᢚไຠᯝ࡟ࡼࡿ࣓ࣛࣀࢧ࢖ࢺቑṪ࡟ᑐࡍࡿࢩࢼࣟࣆࢡࣜࣥ࡟ࡼࡿᢚไຠᯝ 㸦A㸧࣓ࣛࣀࢧ࢖ࢺࡢL-DOPAᰁⰍ 㸦A,B㸧UV↷ᑕ࡟ࡼࡿ࣓ࣛࣀࢧ࢖ࢺቑṪ࡬ࡢCPࡢຠᯝࠋDBA/2 ࣐࢘ࢫࡣ↓సⅭ࡟ 4 ⩌࡟ศࡅࠊྛ⩌ᙜࡓ ࡾᑡ࡞ࡃ࡜ࡶ7 ༉⏝࠸ࡓࠋCPᢞ୚⩌ࡣࠊ462.2 mg/kg㸦ࢩࢼࣟࣆࢡࣜࣥ 3 mg/kg࡟┦ᙜ㸧ࡲࡓࡣ 92.4 mg/kg 㸦ࢩࢼࣟࣆࢡࣜࣥ0.6 mg/kg࡟┦ᙜ㸧ࢆ㐃᪥⤒ཱྀᢞ୚ࡋࡓࠋUV↷ᑕ⩌࡜ࢥࣥࢺ࣮ࣟࣝ⩌࡟ࡣࠊ462.2 mg/kg ࡢࢹ࢟ࢫࢺࣜࣥࢆྠᵝ࡟ᢞ୚ࡋࡓࠋࢹ࣮ࢱࡣᖹᆒsS.D.ࠊ᭷ពᕪࡣANOVA࡟ࡼࡾ ** p<0.01ࠊn.s. ᭷ពᕪ ࡞ࡋ࡜♧ࡋࡓࠋscale bar = 500μm. A B

(29)

⪃ ⪃ ⪃ ⪃ ᐹᐹᐹᐹ   ⣸እ⥺ࡣ⓶⭵࡟᭷ᐖ࡞⎔ቃせᅉࡢ㸯ࡘ࡛࠶ࡾࠊ⓶⭵⪁໬ࡢཎᅉ࡛࠶ࡿࡇ࡜ࡀ▱ࡽࢀ࡚ ࠸ࡿ7,41,42ࠋ⣸እ⥺࡟ࡼࡾ⓶⭵࡛ࡣIL-1ࠊTNF-αྵࡴ⅖⑕ᛶࢧ࢖ࢺ࢝࢖ࣥ43-46MMP-1, bFGF ࡀ⏘⏕ࡉࢀࡿ15,16NF-κB ࡣච␿⅖⑕཯ᛂࡢỴᐃⓗᅉᏊ࡛ࠊ⅖⑕ᛶࢧ࢖ࢺ࢝࢖࡛ࣥ࠶ ࡿIL-1 ࡜ TNF-αࡀ NF-κB ࢆㄏⓎࡍࡿࡇ࡜ࡀ▱ࡽࢀ࡚࠸ࡿ37NF-κB ࡣ࢔ࣞࣝࢠ࣮ᛶ⓶⭵ ⅖ࡸ஝Ⓞࠊ⓶⭵ࡀࢇࢆྵࡴࡉࡲࡊࡲ࡞⓶⭵⑓࡟ࡶ㛵ಀࡋ12ࠊࡲࡓࠊ⣸እ⥺࡟ࡼࡗ࡚άᛶ໬ ࡉࢀࠊIL-1ࠊTNF-αࠊMMP-1ࠊbFGF ࡞࡝ࡢ㑇ఏᏊⓎ⌧ࢆㄏⓎࡍࡿࡇ࡜࡛⓶⭵ࡢ⪁໬ࢆ㉳ࡇ ࡍ࡜ሗ࿌ࡉࢀ࡚࠸ࡿ10,11ࠋNF-κB ࡢ㌿෗άᛶ㜼ᐖࡣࠊ⣸እ⥺࡟ࡼࡗ࡚ㄏⓎࡉࢀࡿ⑓ⓗ࡞ኚ ໬ࡸග⪁໬ࡢቑᝏࢆண㜵ࡍࡿୖ࡛㔜せ࡞ᙺ๭ࢆᯝࡓࡋ࡚࠸ࡿ࡜⪃࠼ࡽࢀࡿࠋࡇࢀࡲ࡛࡟᪤ ▱ࡢNF-κB 㜼ᐖ๣࡛࠶ࡿ parthenolide ࡢ⣸እ⥺࡟ࡼࡾㄏᑟࡉࢀࡿග⪁໬㜵Ṇస⏝ࡸ NF-κB 㜼ᐖ๣ࡢᒁᡤ㐺⏝࡟ࡼࡿග⪁໬ࡢ㜵Ṇࡀሗ࿌ࡉࢀ࡚࠸ࡿ18,34 ᮏ◊✲࡟࠾࠸࡚ࠊ࢔࣮ࢸ࢕ࢳ࣮ࣙࢡࡀຠᯝⓗ࡟NF-κB ࡢ㌿෗άᛶࢆ㜼ᐖࡋࠊග⪁໬ࣉࣟ ࢭࢫࢆ㜵Ṇ࡛ࡁࡿ࡜ሗ࿌ࡋࡓࠋࡲࡓࠊ࢔࣮ࢸ࢕ࢳ࣮ࣙࢡࡢᡂศࡢ㸯ࡘ࡛࠶ࡿࢩࢼࣟࣆࢡࣜ ࣥࡀᢠග⪁໬స⏝ࢆᣢࡘࡇ࡜ࡶ☜ㄆࡋࡓࠋࢩࢼࣟࣆࢡࣜࣥࡀNF-κB㸦p65㸧ࡢ㌿෗άᛶࢆ 㜼ᐖࡋࡓࡇ࡜࠿ࡽࠊࢩࢼࣟࣆࢡࣜࣥࡢNF-κB 㜼ᐖࡢ୺せ࡞ࢱ࣮ࢤࢵࢺࡣࠊI-κB ࡢಟ㣭ࠊศ ゎࡼࡾࡶୗὶ࡟࠶ࡿ࡜⪃࠼ࡽࢀࡿࠋࡉࡽ࡟ࠊࢩࢼࣟࣆࢡࣜࣥࡣNF-κB ࡢ᰾⛣⾜ࢆ㜼ᐖࡋࡓࠋ ࡼࡗ࡚ࠊస⏝ᶵᗎࡢ1 ࡘ࡜ࡋ࡚ࢩࢼࣟࣆࢡࣜࣥࡀάᛶ໬ࡉࢀࡓ NF-κB ࡢ᰾⛣⾜ࢆ㜼ᐖࡍࡿ ࡇ࡜ࡀ♧၀ࡉࢀࡓࠋࡲࡓࠊࢩࢼࣟࣆࢡࣜࣥࡢ⤒ཱྀᢞ୚ࡀ⾲⓶ࡢ⫧ཌࡸ࣓ࣛࣀࢧ࢖ࢺࡢ㐣ቑ Ṫ࡜࠸ࡗࡓ⣸እ⥺࡟ࡼࡾᘬࡁ㉳ࡇࡉࢀࡿ⓶⭵ࡢග⪁໬ࢆᢚไ࡛ࡁࡿࡇ࡜ࢆ᫂ࡽ࠿࡟ࡋࡓࠋ

(30)

⤖ ⤖ ⤖ ⤖ㄽㄽㄽㄽ ᮏ◊✲࡟࠾࠸࡚ࠊࢩࢼࣟࣆࢡࣜࣥࡀ⾲⓶ࡢ⫧ཌࡸ࣓ࣛࣀࢧ࢖ࢺࡢ㐣ቑṪ࡜࠸ࡗࡓග⪁໬ ࢆᢚไ࡛ࡁࡿࡇ࡜ࢆ᫂ࡽ࠿࡟ࡋࡓࠋ⓶⭵ග⪁໬ࡢࣉࣟࢭࢫࡢ୺ᅉࡣNF-κB ࡛࠶ࡿ࡜࠸࠺ࡇ ࡜࡟ᇶ࡙ࡁࠊࢩࢼࣟࣆࢡࣜࣥࡢ⤒ཱྀᢞ୚ࡀNF-κB ࡢ㌿෗άᛶࢆ㜼ᐖࡍࡿࡇ࡜࡟ࡼࡾග⪁໬ ࡟ᑐࡋ࡚ຠᯝⓗ࡞ࡇ࡜ࢆ⣽⬊ࡸ࣐࢘ࢫࢆ⏝࠸ࡓᐇ㦂ࢆ㏻ࡌ࡚ド࡛᫂ࡁࡓࠋ ࡇࡢ࢔࣮ࢸ࢕ࢳ࣮ࣙࢡᢳฟ≀ࡣ໬⢝ရࡸ⨾ᐜ┠ⓗࡢࢧࣉ࣓ࣜࣥࢺ࡞࡝࠸ࡃࡘ࠿ࡢၟရ࡟ ᛂ⏝ࡉࢀ࡚࠾ࡾࠊࢩࢼࣟࣆࢡࣜࣥࡢ౑⏝࡟ࡼࡿග⪁໬㜵Ṇࡢ࣓࢝ࢽࢬ࣒ࡀࡉࡽ࡟ゎ᫂ࡉࢀ ࡿࡇ࡜ࡀᮇᚅࡉࢀࡿࠋ ㅰ㎡ ㅰ㎡ ㅰ㎡ ㅰ㎡  ✏ࢆ⤊ࢃࡿ࡟⮫ࡳࠊᮏ◊✲ࡢ㐙⾜࡟㝿ࡋ࡚ࠊ⤊ጞᚚᣦᑟ࡜ࡈ㠴᧡ࢆ㈷ࡾࡲࡋࡓᒱ㜧኱Ꮫ ኱Ꮫ㝔㐃ྜ๰⸆་⒪᝟ሗ◊✲⛉๰⸆⛉Ꮫᑓᨷ ㉥ᑿ ᖾ༤ ᩍᤵ࡟ᚰ࠿ࡽឤㅰ࠸ࡓࡋࡲࡍࠋ  ᮏ◊✲࡟㝿ࡋࠊpGL3-4kBwt-lucࠊpCMV-p65 ࢆᥦ౪࠸ࡓࡔ࠸ࡓྡྂᒇᕷ❧኱Ꮫ኱Ꮫ㝔་ Ꮫ◊✲⛉⣽⬊ศᏊ⏕≀Ꮫศ㔝 ᒸᮏ ᑦ ᩍᤵ࡟ཌࡃᚚ♩⏦ࡋୖࡆࡲࡍࠋ  ᮏ◊✲࡟㝿ࡋ⤊ጞ῝࠸ࡈ⌮ゎࢆ࠸ࡓࡔࡁࡲࡋࡓ୍୸ࣇ࢓ࣝࢥࢫᰴᘧ఍♫ Ᏻ⸨ⰾᙪ♫㛗ࠊ ᆤ஭ㄔ㛤Ⓨ㒊㛗࡟῝ㅰ⮴ࡋࡲࡍࠋ

(31)

ཧ⪃ᩥ⊩ ཧ⪃ᩥ⊩ ཧ⪃ᩥ⊩ ཧ⪃ᩥ⊩

1. Son TG.; Camandola S.; Mattson MP. 2008. Hormetic dietary phytochemicals. Neuromolecular Med. 10, 4, 236.

2. Mattson MP.; Cheng A. 2006. Neurohormetic phytochemicals: low-dose toxins that induce adaptive neuronal stress responses. Trends Neurosci. 29, 11, 632.

3. Calabrese V.; Cornelius C.; Dinkova-Kostova AT.; Iavicoli I.; Di Paola R.; Koverech A.;

Cuzzocrea S.; Rizzarelli E.; Calabrese EJ. 2012. Cellular stress responses, hormetic phytochemicals and vitagenes in aging and longevity. Biochim Biophys Acta. 1822, 5, 753.

4. Iddamalgoda A.; Le QT.; Ito K.; Tanaka K.; Kojima H.; Kido H. 2008. Mast cell tryptase and photoaging: possible involvement in the degradation of extra cellular matrix and basement membrane proteins. Arch Dermatol Res. 300, 1, 69.

5. Simons R.; Gruppen H.; Bovee TF.; Verbruggen MA.; Vincken JP. 2012. Prenylated

isoflavonoids from plants as selective estrogen receptor modulators (phytoSERMs). Food Funct. 3, 8, 810.

6. Shieh DE.; Liu LT.; Lin CC. 2000. Antioxidant and free radical scavenging effects of baicalein, baicalin and wogonin. Anticancer Res. 20, 5A, 2861.

7. Wulf, H.C.; Sandby-Moller, J.; Kobayashi, T.; Gniadecki, R. 2004. Skin aging and natural photoprotection. Micron 35, 185.

(32)

9. Situm, M.; Bulijan, M.; Cavka, V.; Bulat, V.; Krolo, I.; Mihic, LL. 2010. Skin changes in the elderly people-how strong is the influence of the UV radiation on skin aging? Coll Antropol. 34, 2, 9.

10. Brenneisen, P.; Sies, H.; Scharffetter-Kochanek, K. 2002. Ultraviolet-B irradiation and matrix methalloproteinases: from induction via signaling to initial events. Ann N Y Acad Sci. 973, 31. 11. Hirobe, T.; Furuya, R.; Akiu, S.; Ifuku, O.; Fukuda, M. 2003. Keratinocytes control the proliferation and differentiation of cultured epidermal melanocytes from ultraviolet radiation B-induced pigmented spots in the dorsal skin of hairless mice. Pigment Cell Res. 15, 391. 12. Bell, S.; Degitz, K.; Quirling, M.; Jilg, N.; Page, S.; Brand, K. 2003. Involvement of NF-κB signalling in skin physiology and disease. Cell Signal. 15, 1.

13. Collantes E.; Blázquez M V.; Mazorra V.; Macho A.; Aranda E.; Muñoz E. 1998. Nuclear factor-κB activity in T cells from patients with rheumatic diseases: A preliminary report. Ann Rheum Dis. 57, 738.

14. Watanabe N.; Fujita T. 1996. NF-κB system. Transcription Factors: The pivotal roles in the regulation of biological functions. 41, 8, 1198.

15.Barchowsky, A.; Frleta, D.; Vincenti, M.P. 2000. Integration of the NF-κB and

mitogen-activated protein kinase/AP-1 pathway at the collagenase-1 promotor: divergence of IL-1 and TNF-dependent signal transduction in rabbit primary synovial fibroblasts. Cytokine 12, 1469. 16.Wlaschek, M.; Heinen, G.; Poswig, A.; Schwarz, A.; Krieg, T.; Scharffetter-Kochanek, K. 1994. UVA-induced autocrine stimulation of fibroblast-derived collagenase/MMP-1 by interrelated loops

(33)

of interleukin-1 and interleukin-6. Photochem Photobiol. 59, 550.

17. Tanaka, K.; Hasegawa, J.; Asamitsu, K.; Okamoto, T. 2005. Prevention of the Ultraviolet

B-Mediated Skin Photoaging by a Nuclear Factor κB Inhibitor, Parthenolide. J Pharmacol Exp Ther. 315, 624.

18. Tanaka, K.; Asamitsu, K.; Uranishi, H.; Iddamalgoda, A.; Ito, K.; Kojima, H.; Okamoto, T. 2010. Protecting Skin Photoaging by NF-kappaB Inhibitor. Curr Drug Metab. 11, 431.

19. Sabourin, CL.; Kusewitt, DF.; Applegate, LA.; Budge, CL.; Ley, R.D. 1993. Expression of fibroblast growth factors in ultraviolet radiation-induced corneal tumors and corneal tumor cell lines from Monodelphis domestica. Mol Carcinog. 7, 197.

20. Wakisaka, N.; Murono, S.; Yoshizaki, T.; Furukawa, M.; Pagano, J.S. 2002. Epstein-Barr virus latent membrane protein 1 induces and causes release of fibroblast growth factor-2. Cancer Res. 1, 62, 6337.

21. Duckett, CS.; Perkins, ND.; Kowalik, TF.; Schmid, RM.; Huang, ES.; Baldwin, AS Jr.; Nabel, GJ. 1993 Dimerization of NF-KB2 with RelA(p65) regulates DNA binding, transcriptional activation, and inhibition by an I kappa B-alpha (MAD-3). Mol Cell Biol. 13, 1315.

22.Wullaert, A.; Bonnet, MC.; Pasparakis, M. 2011. NF-țB in the regulation of epithelial homeostasis and Inflammation. Cell Res. 21, 146.

23. Okamoto, T.; Sakurada, S.; Yang, JP.; Merin, J.P. 1997. Regulation of NF-κB and Disease control: Identification of a novel serine kinase and thioredoxin as effectors for signal transduction pathway for NF-κB activation. Curr Top Cell Regul. 35, 149.

(34)

24. Hayden, MS.; Ghosh, S. 2004. Signaling to NF-κB. Genes Dev. 15, 18, 2195.

25. Kwok, B.H.; Koh, B.; Ndubuisi, M.I.; Elofsson, M.; Crews, C.M. 2001. The anti-inflammatory natural product parthenolide from the medical herb Feverfew directly binds to and inhibits IκB kinase. Chem Biol. 8, 759.

26. Saliou, C.; Kitazawa, M.; McLaughlin, L.; Yang, J.P.; Lodge, JK.; Tetsuka, T.; Iwasaki, K.; Cillard, J.; Okamoto, T.; Packer, L. 1999. Antioxidants modulate acute solar ultraviolet

radiation-induced NF-kappaB activation in a human keratinocyte cell line. Free Radic Biol Med. 26, 174.

27. Siyuan, Z.; Yen-Kim, W.; Choon-Nam, O.; Han-Ming, S. 2005. Anti-Cancer potential of Sesquiterpene lactones: Bioactivity and molecular mechanisms. Curr. Med. Chem. 5, 239 28. Mehmetçik G.; Ozdemirler G.; Koçak-Toker N.; Cevikbaú U.; Uysal M. 2008. Effect of

pretreatment with artichoke extract on carbon tetrachloride-induced liver injury and oxidative stress. Exp Toxicol pathol. 60, 475.

29. Samuhasaneeto S., Thong-Ngam D., Kulaputana O., Suyasunanont D., Klaikeaw N. 2009. Curcumin Decreased Oxidative Stress, Inhibited NF-țB Activation, and Improved Liver Pathology in Ethanol-Induced Liver Injury in Rats. J Biomed Biotechnol. 2009. 981963.

30. Ishida K.; Kojima R.; Tsuboi M.; Tsuda Y.; Ito M. 2010. Effects of artichoke leaf extract on acute gastric mucosal injury in rats. Biol Pharm Bull. 33, 223.

31. Zimmermann, S.; Kaiser, M.; Brun, R.; Hamburger, M.; Adams M. 2012. Cynaropicrin: the first plant natural product with in vivo activity against Trypanosoma brucei. Planta Med. 78, 6, 553.

(35)

32. Cho, JY.; Kim, AR.; Jung, JH.; Chun, T.; Rhee, MH.; Yoo, ES. 2004. Cytotoxic and pro-apoptotic activities of cynaropicrin, a sesquiterpene lactone, on the viability of leukocyte cancer cell lines. Eur J Pharmacol. 25, 492, 85

33. Sato, T.; Asamitsu, K.; Yang, J.P.; Takahashi, N.; Tetsuka, T.; Yoneyama, A.; Kanagawa, A.; Okamoto, T. 1998. Inhibition of human immunodeficiency virus type 1 replication by a

bioavailable serine/threonine kinase inhibitor, fasudil hydrochloride. AIDS Res Hum Retroviruses. 1, 14, 293.

34. Tanaka, K.; Hasegawa, J.; Asamitsu, K.; Okamoto, T. 2007. Magnolia ovovata extract and its active component magnolol prevent skin photoaging via inhibition of nuclear factor kappaB. Eur J Pharmacol. 22, 565, 212.

35. Tetsuka, T.; Uranishi, H.; Imai, H.; Ono, T.; Sonta, S.; Takahashi, N.; Asamitsu, K.; Okamoto, T. 2000. Inhibition of nuclear factor-κB-mediated transcription by association with the amino-terminal enhancer of split, a Groucho-related protein lacking WD40 repeats. J Biol Chem. 11, 275, 4383. 36. Uranishi, H.; Tetsuka, T.; Yamashita, M.; Asamitsu, K.; Shimizu, M.; Itoh, M.; Okamoto, T. 2001. Involvement of the pro-oncoprotein TLS (translocated in liposarcoma) in nuclear factor-κB p65-mediated transcription as a coactivator. J Biol Chem. 20, 276, 13395.

37. Sakurada, S.; Kato, T.; Okamoto, T. 1996. Induction of cytokines and ICAM-1 by proinflammatory cytokines in primary rheumatoid synovial fibroblasts and inhibition by N-acetyl-L-cysteine and aspirin. Int Immunol. 8, 1483.

(36)

activates a nitric oxide-dependent hypothalamopituitary proopiomekanocortin pathway and modulates functions of alpha melanocyte-stimulating hormone-responsive cells. J Investig Dermatol. 120, 123.

39. Pittelkow, M.R.; Shipley, G.D. 1989. Serum-free culture of normal human melanocytes: growth kinetics and growth factor requirements. J Cell Physiol. 140, 565.

40. Bielenberg, DR.; Bucana, CD.; Sanchez, R.; Donawho, CK.; Kripke, ML.; Fidler, IJ. 1998. Molecular regulation of UVB-induced cutaneous angiogenesis. J Invest Dermatol. 111, 864. 41. Kligman, L.H. 1989. Photoaging. Manifestations, prevention, and treatment. Clin Geriatr Med. 5, 235.

42. Ulrich, C.; Schmook, T.; Sachse, MM.; Sterry, W.; Stockfleth, E. 2004. Comparative

epidemiology and pathogenic factors for non-melanoma skin cancer in organ transplant patients. Dermatol Surg. 30, 622.

43. Corsini, E.; Sangha, N.; Feldman, SR. 1997. Epidermal stratification reduces the effects of UVB (but not UVA) on keratinocyte cytokine production and cytoxicity. Photodermatol Photoimmunol Photomed. 13, 147.

44. Fisher, G.J.; Datta, S.C.; Talwar, H.S.; Wang, Z.Q.; Varani, J.; Kang, S.; Voorhees, J.J. 1996. Molecular basis of sun-induced premature skin ageing and retinoid antagonism. Nature 379, 335. 45. Yarosh, D.; Both, D.; Kibitel, J.; Anderson, C.; Elmets, C.; Brash, D.; Brown, D. 2000. Regulation of TNFα production and release in human and mouse keratinocytes and mouse skin after UV-B irradiation. Photodermatol Photoimmunol Photomed. 16, 263.

(37)

46. Wlaschek, M.; Heinen, G.; Poswig, A.; Schwarz, A.; Krieg, T. Scharffetter-Kochanek, K., 1994. UVA-induced autocrine stimulation of fibroblast-derived collagenase/MMP-1 by interrelated loops of interleukin-1 and interleukin-6. Photochem Photobiol. 59, 550.

ཧ⪃㈨ᩱ࣭⥲ㄝ ཧ⪃㈨ᩱ࣭⥲ㄝ ཧ⪃㈨ᩱ࣭⥲ㄝ ཧ⪃㈨ᩱ࣭⥲ㄝ 1. ㈨⏕ᇽ, ⨾ࡋࡃᖺࢆ㔜ࡡࡿࣄࣥࢺϪ, ồ㱟ᇽ, 1997, 83 2. A. M. Kligman, ຍ㱋࡜⓶⭵, Ύ⮳᭩㝔, 1986. 3. ᒸ⏣⛱, ᪂ゞཎⰍ∾㔝࿴₎⸆ⲡᅯ㤋, ໭㝯㤋, 2002, 554. 4. ᰗ᐀Ẹ, ௚, ୡ⏺᭷⏝᳜≀஦඾, ᖹซ♫, 1989, 351. 5. ⏣㒊஭‶⏨, ࣁ࣮ࣈࢫࣃ࢖ࢫ㤋, ᑠᏛ㤋, 2000, 203. 6. ᮌᮧ㝧஧㑻, ⰼ࡜ᶞࡢ኱㎡඾, ᯽᭩ᡣ, 1996, 282. 7. ఀ⃝୍⏨, ⸆ⲡ࣮࢝ࣛ኱㎡඾, ୺፬ࡢ཭♫, 1998, 699. 8. ኱ሙ⚽❶, ᮅ᪥ⓒ⛉࣭᳜≀ࡢୡ⏺Ϩ, ᮅ᪥᪂⪺♫, 1997, 26. 9. ࢔ࣥࢻ࣮࣭ࣜࣗࢩ࢙ࣦ࢓࢚ࣜ, ୡ⏺⸆⏝᳜≀ⓒ⛉஦඾, ㄔᩥᇽ᪂ග♫, 2000, 196.

参照

関連したドキュメント

Amount of Remuneration, etc. The Company does not pay to Directors who concurrently serve as Executive Officer the remuneration paid to Directors. Therefore, “Number of Persons”

何人も、その日常生活に伴う揮発性有機 化合物の大気中への排出又は飛散を抑制

何人も、その日常生活に伴う揮発性有機 化合物の大気中への排出又は飛散を抑制

歴史的にはニュージーランドの災害対応は自然災害から軍事目的のための Civil Defence 要素を含めたものに転換され、さらに自然災害対策に再度転換がなされるといった背景が

○ また、 障害者総合支援法の改正により、 平成 30 年度から、 障害のある人の 重度化・高齢化に対応できる共同生活援助

当該 領域から抽出さ れ、又は得ら れる鉱物その他の 天然の物質( から までに 規定するもの

※1 廃棄物等の発生抑制(リデュース:Reduce,原材料を効率的に製品を長期間使用する等により廃棄物になる